# L_2009011EN.01000601.xml

| 16.1.2009 | EN | Official Journal of the European Union | L 11/6 |
| --- | --- | --- | --- |

16.1.2009

EN

Official Journal of the European Union

L 11/6

---

COMMISSION DIRECTIVE 2009/2/EC

of 15 January 2009

amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (1), and in particular Article 28 thereof,

Whereas:

| (1) | Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical. |
| --- | --- |

(1)

Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

| (2) | Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances. |
| --- | --- |

(2)

Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

| (3) | Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances. |
| --- | --- |

(3)

Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

| (4) | Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses. |
| --- | --- |

(4)

Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

| (5) | Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement. |
| --- | --- |

(5)

Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

| (6) | The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties. |
| --- | --- |

(6)

The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

| (7) | As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances. |
| --- | --- |

(7)

As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

| (8) | The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive. |
| --- | --- |

(8)

The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

| (9) | The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations, |
| --- | --- |

(9)

The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,

HAS ADOPTED THIS DIRECTIVE:

Article 1

Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

| (a) | the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex; |
| --- | --- |

(a)

the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;

| (b) | the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC; |
| --- | --- |

(b)

the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;

| (c) | the entries set out in Annex 1C to this Directive are deleted. |
| --- | --- |

(c)

the entries set out in Annex 1C to this Directive are deleted.

Article 2

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.

Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 4

This Directive is addressed to the Member States.

Done at Brussels, 15 January 2009.

For the Commission

Stavros DIMAS

Member of the Commission

---

(1)  
  OJ 196, 16.8.1967, p. 1.

1

---

ANNEX 1A

| Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001-002-00-4 | aluminium lithium hydride | | 240-877-9 | 16853-85-3 | F; R15
  C; R35 | F; C
  R: 15-35
  S: (1/2-)7/8-26-36/37/39-43-45 | | |
| 005-006-00-7 | dibutyltin hydrogen borate | E | 401-040-5 | 75113-37-0 | Muta. Cat. 3; R68
  Repr. Cat. 2; R60-61
  T; R48/25
  Xn; R21/22
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 60-61-21/22-41-43-48/25-68-50/53
  S: 53-45-60-61 | | |
| 006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | A | — | — | T+; R26/27/28
  R32
  N; R50-53 | T+; N
  R: 26/27/28-32-50/53
  S: (1/2-)7-28-29-45-60-61 | | |
| 006-015-00-9 | diuron (ISO);
  3-(3,4-dichlorophenyl)-1,1-dimethylurea | | 206-354-4 | 330-54-1 | Carc. Cat. 3; R40
  Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-40-48/22-50/53
  S: (2-)13-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-40-48/22-50/53
  10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53
  2,5 % ≤ C < 10 %: Xn, N; R40-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-076-00-1 | mancozeb (ISO);
  manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt | | — | 8018-01-7 | Repr. Cat. 3; R63
  R43
  N; R50 | Xn; N
  R: 43-63-50
  S: (2-)36/37-46-61 | C ≥ 5 %: Xn, N; R43-63-50
  2,5 ≤ C < 5 %: Xi, N; R43-50
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 006-077-00-7 | maneb (ISO);
  manganese ethylenebis(dithiocarbamate) (polymeric) | | 235-654-8 | 12427-38-2 | Repr. Cat. 3; R63
  Xn; R20
  Xi; R36
  R43
  N; R50-53 | Xn; N
  R: 20-36-43-63-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-36-43-63-50/53
  20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53
  5 % ≤ C < 20 %: Xn, N; R43-63-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-084-00-5 | carbosulfan (ISO);
  2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate | | 259-565-9 | 55285-14-8 | T+; R26
  T; R25
  R43
  N; R50-53 | T+; N
  R: 25-26-43-50/53
  S: (1/2-)28-36/37-38-45-63-60-61 | | |
| 006-088-00-7 | benfuracarb (ISO);
  ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate | | — | 82560-54-1 | Repr. Cat. 3; R62
  T; R23
  Xn; R22
  N; R50-53 | T; N
  R: 22-23-62-50/53
  S: (1/2-)36/37-45-60-61 | | |
| 007-002-00-0 | nitrogen dioxide; [1]
  dinitrogen tetraoxide [2] | | 233-272-6 [1]
  234-126-4 [2] | 10102-44-0 [1]
  10544-72-6 [2] | O; R8
  T+; R26
  C; R34 | O; T+
  R: 8-26-34
  S: (1/2-)9-26-28-36/37/39-45 | C ≥ 10 %: T+; R26-34
  5 % ≤ C < 10 %: T; R23-34
  1 % ≤ C < 5 %: T; R23-36/37/38
  0,5 % ≤ C < 1 %: Xn; R20-36/37/38
  0,1 % ≤ C < 0,5 %: Xn; R20 | 5 |
| 015-041-00-X | malathion (ISO);
  1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;
  [containing ≤ 0,03 % isomalathion] | | 204-497-7 | 121-75-5 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  1 % ≤ C < 25 %: Xi, N; R43-50/53
  0,025 % ≤ C < 1 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-100-00-X | phoxim (ISO);
  α-(diethoxyphosphinothioylimino) phenylacetonitrile | | 238-887-3 | 14816-18-3 | Repr. Cat. 3; R62
  Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-62-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-62-50/53
  5 % ≤ C < 25 %: Xn, N; R43-62-50/53
  1 % ≤ C < 5 %: Xi, N; R43-50/53
  0,025 % ≤ C < 1 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-102-00-0 | tris(2-chloroethyl)phosphate | E | 204-118-5 | 115-96-8 | Carc. Cat. 3; R40
  Repr. Cat. 2; R60
  Xn; R22
  N; R51-53 | T; N
  R: 60-22-40-51/53
  S: 53-45-61 | | |
| 015-155-00-X | glufosinate ammonium (ISO);
  ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate | E | 278-636-5 | 77182-82-2 | Repr. Cat. 2; R60
  Repr. Cat. 3; R63
  Xn; R20/21/22-48/20/22 | T
  R: 60-20/21/22-48/20/22-63
  S: 53-45 | | |
| 016-009-00-8 | disodium sulfide;
  sodium sulfide | | 215-211-5 | 1313-82-2 | T; R24
  Xn; R22
  C; R34
  R31
  N; R50 | T; C; N
  R: 22-24-31-34-50
  S: (1/2-)26-36/37/39-45-61 | | |
| 017-009-00-0 | ammonium perchlorate;
  [containing ≥ 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R3
  O; R9 | E
  R: 3-9
  S: (2-)14-16-36/37 | | |
| 024-004-00-7 | sodium dichromate | E | 234-190-3 | 10588-01-9 | O; R8
  Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Repr. Cat. 2; R60-61
  T+; R26
  T; R25-48/23
  Xn; R21
  C; R34
  R42/43
  N; R50-53 | O; T+; N
  R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
  S: 53-45-60-61 | C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53
  10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53
  7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53
  5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53
  3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53
  2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53
  1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53
  0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53
  0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53
  0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43
  0,1 % ≤ C < 0,2 %: T; R45-46-20 | 3 |
| 027-002-00-4 | cobalt oxide | | 215-154-6 | 1307-96-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  2,5 % ≤ C < 25 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 027-003-00-X | cobalt sulfide | | 215-273-3 | 1317-42-6 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 028-003-00-2 | nickel monoxide; [1]
  nickel oxide; [2]
  bunsenite [3] | E | 215-215-7 [1]
  234-323-5 [2]
  - [3] | 1313-99-1 [1]
  11099-02-8 [2]
  34492-97-2 [3] | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-004-00-8 | nickel dioxide | E | 234-823-3 | 12035-36-8 | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-005-00-3 | dinickel trioxide | E | 215-217-8 | 1314-06-3 | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-006-00-9 | nickel (II) sulfide; [1]
  nickel sulfide; [2]
  millerite [3] | E | 240-841-2 [1]
  234-349-7 [2]
  - [3] | 16812-54-7 [1]
  11113-75-0 [2]
  1314-04-1 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 028-007-00-4 | trinickel disulfide;
  nickel subsulfide; [1]
  heazlewoodite [2] | E | 234-829-6 [1]
  - [2] | 12035-72-2 [1]
  12035-71-1 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 028-008-00-X | nickel dihydroxide; [1]
  nickel hydroxide [2] | E | 235-008-5 [1]
  234-348-1 [2] | 12054-48-7 [1]
  11113-74-9 [2] | Carc. Cat. 1; R49
  Repr. Cat. 2; R61
  Muta. Cat. 3; R68
  T; R48/23
  Xn; R20/22
  Xi; R38
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-38-42/43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | | 407-580-8 | 130201-51-3 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 033-005-00-1 | arsenic acid and its salts with the exception of those specified elsewhere in this Annex | AE | — | — | Carc. Cat. 1; R45
  T; R23/25
  N; R50-53 | T; N
  R: 45-23/25-50/53
  S: 53-45-60-61 | | |
| 034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | A | — | — | T; R23/25
  R33
  N; R50-53 | T; N
  R: 23/25-33-50/53
  S: (1/2-)20/21-28-45-60-61 | | |
| 047-001-00-2 | silver nitrate | | 231-853-9 | 7761-88-8 | O; R8
  C; R34
  N; R50-53 | O; C; N
  R: 8-34-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 050-002-00-0 | cyhexatin (ISO);
  hydroxytricyclohexylstannane;
  tri(cyclohexyl)tin hydroxide | | 236-049-1 | 13121-70-5 | Xn; R20/21/22
  N; R50-53 | Xn; N
  R: 20/21/22-50/53
  S: (2-)13-60-61 | C ≥ 25 %: Xn, N; R20/21/22-50/53
  0,025 % ≤ C < 25 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 050-003-00-6 | fentin acetate (ISO);
  triphenyltin acetate | | 212-984-0 | 900-95-8 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25-48/23
  Xi; R37/38-41
  N; R50-53 | T+; N
  R: 24/25-26-37/38-40-41-48/23-63-50/53
  S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
  20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
  10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
  7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
  5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
  3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
  2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
  1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
  0,25 % ≤ C < 1 %: Xn, N; R20-51/53
  0,1 % ≤ C < 0,25 %: Xn; R20-52/53
  0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-004-00-1 | fentin hydroxide (ISO);
  triphenyltin hydroxide | | 200-990-6 | 76-87-9 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25-48/23
  Xi; R37/38-41
  N; R50-53 | T+; N
  R: 24/25-26-37/38-40-41-48/23-63-50/53
  S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
  20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
  10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
  7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
  5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
  3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
  2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
  1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
  0,25 % ≤ C < 1 %: Xn, N; R20-51/53
  0,1 % ≤ C < 0,25 %: Xn; R20-52/53
  0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-008-00-3 | tributyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R25-48/23/25
  Xn; R21
  Xi; R36/38
  N; R50-53 | T; N
  R: 21-25-36/38-48/23/25-50/53
  S: (1/2-)36/37/39-45-60-61 | C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53
  1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53
  0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53
  0,025 % C < 0,25 %: R52/53 | 1 |
| 050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R23/24/25
  N; R50-53 | T; N
  R: 23/24/25-50/53
  S: (1/2-)26-27-28-45-60-61 | C ≥ 1 %: T, N; R23/24/25-50/53
  0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | 1 |
| 050-018-00-8 | tin(II) methanesulphonate | | 401-640-7 | 53408-94-9 | C; R34
  Xn; R22
  R43
  N; R51-53 | C; N
  R: 22-34-43-51/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 053-003-00-4 | iodoxybenzene | | — | 696-33-3 | E; R2 | E
  R: 2
  S: (2-)35 | | |
| 053-004-00-X | calcium iodoxybenzoate | C | — | — | E; R2 | E
  R: 2
  S: (2-)35 | | |
| 080-001-00-0 | mercury | E | 231-106-7 | 7439-97-6 | Repr. Cat. 2; R61
  T+; R26
  T; R48/23
  N; R50-53 | T+; N
  R: 61-26-48/23-50/53
  S: 53-45-60-61 | | |
| 080-010-00-X | mercury dichloride;
  mercuric chloride | | 231-299-8 | 7487-94-7 | Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T+; R28
  T; R48/24/25
  C; R34
  N; R50-53 | T+; N
  R: 28-34-48/24/25-62-68-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | A | — | — | T+; R26/28
  R33
  N; R51-53 | T+; N
  R: 26/28-33-51/53
  S: (1/2-)20/21-45-61 | | |
| 601-065-00-3 | A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);
  (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane) | | 416-930-9 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)36/37-61 | | |
| 602-007-00-X | bromoform;
  tribromomethane | | 200-854-6 | 75-25-2 | T; R23
  Xn; R22
  Xi; R36/38
  N; R51-53 | T; N
  R: 22-23-36/38-51/53
  S: (1/2-)28-45-63-61 | | |
| 602-030-00-5 | 1,3-dichloropropene; [1]
  (Z)-1,3-dichloropropene [2] | C D | 208-826-5 [1]
  233-195-8 [2] | 542-75-6 [1]
  10061-01-5 [2] | R10
  T; R24/25
  Xn; R20-65
  Xi; R36/37/38
  R43
  N; R50-53 | T; N
  R: 10-20-24/25-36/37/38-43-65-50/53
  S: (1/2-)36/37-45-60-61 | | |
| 602-054-00-6 | 3-iodpropene;
  allyl iodide | | 209-130-4 | 556-56-9 | F; R11
  C; R34 | F; C
  R: 11-34
  S: (1/2-)7-16-26-45 | | |
| 603-005-00-1 | 2-methylpropan-2-ol;

  tert-butyl alcohol | | 200-889-7 | 75-65-0 | F; R11
  Xn; R20
  Xi; R36/37 | F; Xn
  R: 11-20-36/37
  S: (2-)9-16-46 | | |
| 603-018-00-2 | furfuryl alcohol | | 202-626-1 | 98-00-0 | Carc. Cat. 3; R40
  T; R23
  Xn; R21/22-48/20
  Xi; R36/37 | T
  R: 21/22-23-36/37-40-48/20
  S: (1/2-)36/37-45-63 | | |
| 603-023-00-X | ethylene oxide;
  oxirane | E | 200-849-9 | 75-21-8 | F+; R12
  R6
  Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  T; R23
  Xi; R36/37/38 | F+; T
  R: 45-46-6-12-23-36/37/38
  S: 53-45 | | |
| 603-029-00-2 | bis(2-chloroethyl) ether | | 203-870-1 | 111-44-4 | Carc. Cat. 3; R40
  T+; R26/27/28 | T+
  R: 26/27/28-40
  S: (1/2-)7/9-27-28-36/37-45 | C ≥ 7 %: T+; R26/27/28-40
  1 % ≤ C < 7 %: T; R23/24/25-40
  0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 603-037-00-6 | cellulose nitrate;
  nitrocellulose | T | — | — | E; R3 | E
  R: 3
  S: (2-)35 | | |
| 603-046-00-5 | bis(chloromethyl) ether;
  oxybis(chloromethane) | E | 208-832-8 | 542-88-1 | F; R11
  Carc. Cat. 1; R45
  T+; R26
  T; R24
  Xn; R22 | F; T+
  R: 45-11-22-24-26
  S: 53-45 | C ≥ 25 %: T+; R45-22-24-26
  7 % ≤ C < 25 %: T+; R45-21-26
  3 % ≤ C < 7 %: T; R45-21-23
  1 % ≤ C < 3 %: T; R45-23
  0,1 % ≤ C < 1 %: T; R45-20
  0,001 % ≤ C < 0,1 %: T; R45 | |
| 603-064-00-3 | 1-methoxy-2-propanol;
  monopropylene glycol methyl ether | | 203-539-1 | 107-98-2 | R10
  R67 | R: 10-67
  S: (2-) | | |
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane;
  4-vinylcyclohexene diepoxide | | 203-437-7 | 106-87-6 | Carc. Cat. 3; R40
  T; R23/24/25 | T
  R: 23/24/25-40
  S: (1/2-)36/37-45-63 | C ≥ 1 %: T; R23/24/25-40
  0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane;
  paraldehyde | | 204-639-8 | 123-63-7 | R10 | R: 10
  S: (2-)29 | | |
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
  metaldehyde | | 203-600-2 | 108-62-3 | F; R11
  Xn; R22 | F; Xn
  R: 11-22
  S: (2-)13-16-25-46 | | |
| 606-021-00-7 | N-methyl-2-pyrrolidone;
  1-methyl-2-pyrrolidone | | 212-828-1 | 872-50-4 | Repr. Cat. 2; R61
  Xi; R36/37/38 | T
  R: 61-36/37/38
  S: 53-45 | C ≥ 10 %: T; R61-36/37/38
  5 % ≤ C < 10 %: T; R61 | |
| 607-007-00-3 | salts of oxalic acid with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R21/22 | Xn
  R: 21/22
  S: (2-)24/25 | C ≥ 5 %: Xn; R21/22 | |
| 607-012-00-0 | benzoyl chloride | | 202-710-8 | 98-88-4 | Xn; R20/21/22
  C; R34
  R43 | C
  R: 20/21/22-34-43
  S: (1/2-)26-36/37/39-45 | | |
| 607-037-00-7 | 2-ethoxyethyl acetate;
  ethylglycol acetate | E | 203-839-2 | 111-15-9 | R10
  Repr. Cat. 2; R60-61
  Xn; R20/21/22 | T
  R: 60-61-10-20/21/22
  S: 53-45 | | |
| 607-051-00-3 | MCPA (ISO);
  4-chloro-o-tolyloxyacetic acid | | 202-360-6 | 94-74-6 | Xn; R22
  Xi; R38-41
  N; R50-53 | Xn; N
  R: 22-38-41-50/53
  S: (2-)26-37-39-60-61 | | |
| 607-052-00-9 | salts and esters of MCPA | A | — | — | Xn; R20/21/22
  N; R50-53 | Xn; N
  R: 20/21/22-50/53
  S: (2-)13-60-61 | | |
| 607-085-00-9 | benzyl benzoate | | 204-402-9 | 120-51-4 | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)25-46-61 | | |
| 607-095-00-3 | maleic acid | | 203-742-5 | 110-16-7 | Xn; R22
  Xi; R36/37/38
  R43 | Xn
  R: 22-36/37/38-43
  S: (2-)24-26-28-37-46 | C ≥ 25 %: Xn; R22-36/37/38-43
  20 % ≤ C <25 %: Xi; R36/37/38-43
  0,1 % ≤ C < 20 %: Xi; R43 | |
| 607-103-00-5 | succinic anhydride | | 203-570-0 | 108-30-5 | Xn; R22
  Xi; R36/37 | Xn
  R: 22-36/37
  S: (2-)25-46 | C ≥ 5 %: Xn; R22-36/37
  1 % ≤ C < 5 %: Xi; R36/37 | |
| 607-142-00-8 | propyl chloroformate;
  chloroformic acid propylester;

  n-propyl chloroformate | | 203-687-7 | 109-61-5 | F; R11
  T; R23
  C; R34 | F; T
  R: 11-23-34
  S: (1/2-)16-26-36-45 | | |
| 607-195-00-7 | 2-methoxy-1-methylethyl acetate | | 203-603-9 | 108-65-6 | R10 | R: 10
  S: (2-) | | |
| 607-216-00-X | glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine | | 403-950-8 | — | T+; R26
  Xn; R22
  C; R34
  N; R50 | T+; N
  R: 22-26-34-50
  S: (1/2-)26-36/37/39-38-45-61 | | |
| 607-231-00-1 | clopyralid (ISO);
  3,6-dichloropyridine-2-carboxylic acid | | 216-935-4 | 1702-17-6 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-245-00-8 | tert-butyl acrylate | D | 216-768-7 | 1663-39-4 | F; R11
  Xn; R20/21/22
  Xi; R37/38
  R43
  N; R51-53 | F; Xn; N
  R: 11-20/21/22-37/38-43-51/53
  S: (2-)16-25-37-61 | C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53
  20 % ≤ C < 25 %: Xi; R37/38-43-52/53
  2,5 % ≤ C < 20 %: Xi; R43-52/53
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 607-397-00-5 | A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);
  Ca phenates (branched C10-14 and C18-30 alkylated);
  Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) | | 415-930-6 | — | Repr. Cat. 3; R62
  R43 | Xn
  R: 43-62
  S: (2-)23-36/37 | | |
| 608-005-00-5 | n-butyronitrile | | 203-700-6 | 109-74-0 | F; R11
  T; R23/24/25 | F; T
  R: 11-23/24/25
  S: (1/2-)16-36/37-45-63 | | |
| 608-011-00-8 | oxalonitrile;
  cyanogen | | 207-306-5 | 460-19-5 | F+; R12
  T; R23
  N; R50-53 | F+; T; N
  R: 12-23-50/53
  S: (1/2-)9-16-23-33-45-63-60-61 | | |
| 608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | | 423-740-1 | 10461-98-0 | Xn; R22
  N; R51-53 | Xn; N
  R; 22-51/53
  S: (2-)46-61 | | |
| 609-007-00-9 | 2,4-dinitrotoluene; [1]
  dinitrotoluene [2] | E | 204-450-0 [1]
  246-836-1 [2] | 121-14-2 [1]
  25321-14-6 [2] | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R23/24/25
  Xn; R48/22
  N; R50-53 | T; N
  R: 45-23/24/25-48/22-62-68-50/53
  S: 53-45-60-61 | | |
| 611-028-00-3 | C,C′-azodi(formamide) | | 204-650-8 | 123-77-3 | E; R2
  R42 | E; Xn
  R: 2-42
  S: (2-)22-24-37 | | |
| 611-035-00-1 | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | | 403-660-1 | 107246-80-0 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-044-00-3 | N,N′-diacetylbenzidine | E | 210-338-2 | 613-35-4 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Xn; R20/21/22 | T
  R: 45-20/21/22-68
  S: 53-45 | | |
| 612-050-00-6 | cyclohexylamine | | 203-629-0 | 108-91-8 | R10
  Repr. Cat. 3; R62
  Xn; R21/22
  C; R34 | C
  R: 10-21/22-34-62
  S: (1/2-)26-36/37/39-45 | C ≥ 25 %: C; R21/22-34-62
  10 % ≤ C < 25 %: C; R34-62
  5 % ≤ C < 10 %: Xn; R36/38-62
  2 % ≤ C < 5 %: Xi; R36/38 | |
| 612-076-00-8 | ethyldimethylamine | | 209-940-8 | 598-56-1 | F; R11
  Xn; R20/22
  C; R34 | F; C
  R: 11-20/22-34
  S: (1/2-)3-16-26-36-45 | | |
| 612-099-00-3 | 4-methyl-m-phenylenediamine;
  2,4-toluenediamine | E | 202-453-1 | 95-80-7 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R25
  Xn; R21-48/22
  R43
  N; R51-53 | T; N
  R: 45-21-25-43-48/22-62-68-51/53
  S: 53-45-61 | | |
| 612-101-00-2 | methenamine;
  hexamethylenetetramine | | 202-905-8 | 100-97-0 | F; R11
  R43 | F; Xi
  R: 11-43
  S: (2-)24-37 | | |
| 612-151-00-5 | methyl-phenylene diamine;
  diaminotoluene;
  [technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | E | — | — | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R25
  Xn; R21-48/22
  Xi; R36
  R43
  N; R51-53 | T; N
  R: 45-21-25-36-43-48/22-62-68-51/53
  S: 53-45-61 | | |
| 612-237-00-2 | hydroxylammonium hydrogensulfate;
  hydroxylamine sulfate(1:1); [1]
  hydroxylamine phosphate; [2]
  hydroxylamine dihydrogenphosphate; [3]
  hydroxylamine 4-methylbenzenesulfonate [4] | T | 233-154-4 [1]
  244-077-0 [2]
  242-818-2 [3]
  258-872-5 [4] | 10046-00-1 [1]
  20845-01-6 [2]
  19098-16-9 [3]
  53933-48-5 [4] | E; R2
  Carc. Cat. 3; R40
  Xn; R21/22-48/22
  Xi; R36/38
  R43
  N; R50 | E; Xn; N
  R: 21/22-36/38-40-43-48/22-50
  S: (2-)36/37-61 | | |
| 613-116-00-7 | tolylfluanid (ISO);
  dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
  [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | T+; R26
  T; R48/23
  Xi; R36/37/38
  R43
  N; R50 | T+; N
  R: 26-36/37/38-43-48/23-50
  S: (1/2-)28-36/37/39-45-63-61 | C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50
  10 % ≤ C < 20 %: T+, N; R26-43-48/23-50
  7 % ≤ C < 10 %: T+, N; R26-43-48/20-50
  2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50
  1 % ≤ C < 2,5 %: T; R23-43-48/20
  0,1 % ≤ C < 1 %: Xn; R20 | |
| 615-001-00-7 | methyl isocyanate | | 210-866-3 | 624-83-9 | F; R11
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25
  R42/43
  Xi; R37/38-41 | F; T+
  R: 11-24/25-26-37/38-41-42/43-63
  S: (1/2-)16-26-27/28-36/37/39-45-63 | | |
| 615-004-00-3 | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
  R32
  R52-53 | Xn
  R: 20/21/22-32-52/53
  S: (2-)13-36/37-46-61 | | |
| 615-028-00-4 | ethyl 2-(isocyanatosulfonyl)benzoate | | 410-220-2 | 77375-79-2 | R14
  Xn; R22-48/22
  Xi; R41
  R42/43 | Xn
  R: 14-22-41-42/43-48/22
  S: (2-)8-23-26-30-35-36/37/39 | | |
| 615-030-00-5 | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
  R32
  R52-53 | Xn
  R: 20/21/22-32-52/53
  S: (2-)13-36/37-46-61 | | |
| 615-031-00-0 | thallium thiocyanate | | 222-571-7 | 3535-84-0 | T+; R26/28
  Xn; R21
  R32
  R33
  N; R51-53 | T+; N
  R: 21-26/28-32-33-51/53
  S: (1/2-)13-28-36/37-45-61 | | |
| 615-032-00-6 | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
  R32
  N; R50-53 | Xn; N
  R: 20/21/22-32-50/53
  S: (2-)13-36/37-46-60-61 | | |
| 616-124-00-9 | lithium bis(trifluoromethylsulfonyl)imide | | 415-300-0 | 90076-65-6 | T; R24/25
  Xn; R48/22
  C; R34
  R52-53 | T
  R: 24/25-34-48/22-52/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 617-017-00-X | A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;
  2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene | T | 412-140-3 | 32144-25-5 | E; R2
  O; R7
  R53 | E
  R: 2-7-53
  S: (2-)3/7-14-36/37/39-61 | | |
| 650-016-00-2 | Mineral wool, with the exception of those specified elsewhere in this Annex;
  [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] | AQR | — | — | Carc. Cat. 3; R40 | Xn
  R: 40
  S: (2-)36/37 | | |
| 650-017-00-8 | Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
  [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] | AR | — | — | Carc. Cat. 2; R49 | T
  R: 49
  S: 53-45 | | |

Index No

Chemical name

Notes related to substances

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes related to preparations

001-002-00-4

aluminium lithium hydride

240-877-9

16853-85-3

F; R15

C; R35

F; C

R: 15-35

S: (1/2-)7/8-26-36/37/39-43-45

005-006-00-7

dibutyltin hydrogen borate

E

401-040-5

75113-37-0

Muta. Cat. 3; R68

Repr. Cat. 2; R60-61

T; R48/25

Xn; R21/22

Xi; R41

R43

N; R50-53

T; N

R: 60-61-21/22-41-43-48/25-68-50/53

S: 53-45-60-61

006-007-00-5

salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex

A

—

—

T+; R26/27/28

R32

N; R50-53

T+; N

R: 26/27/28-32-50/53

S: (1/2-)7-28-29-45-60-61

006-015-00-9

diuron (ISO);

3-(3,4-dichlorophenyl)-1,1-dimethylurea

206-354-4

330-54-1

Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-40-48/22-50/53

S: (2-)13-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-40-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53

2,5 % ≤ C < 10 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-076-00-1

mancozeb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt

—

8018-01-7

Repr. Cat. 3; R63

R43

N; R50

Xn; N

R: 43-63-50

S: (2-)36/37-46-61

C ≥ 5 %: Xn, N; R43-63-50

2,5 ≤ C < 5 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

006-077-00-7

maneb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric)

235-654-8

12427-38-2

Repr. Cat. 3; R63

Xn; R20

Xi; R36

R43

N; R50-53

Xn; N

R: 20-36-43-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-36-43-63-50/53

20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53

5 % ≤ C < 20 %: Xn, N; R43-63-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-084-00-5

carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate

259-565-9

55285-14-8

T+; R26

T; R25

R43

N; R50-53

T+; N

R: 25-26-43-50/53

S: (1/2-)28-36/37-38-45-63-60-61

006-088-00-7

benfuracarb (ISO);

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate

—

82560-54-1

Repr. Cat. 3; R62

T; R23

Xn; R22

N; R50-53

T; N

R: 22-23-62-50/53

S: (1/2-)36/37-45-60-61

007-002-00-0

nitrogen dioxide; [1]

dinitrogen tetraoxide [2]

233-272-6 [1]

234-126-4 [2]

10102-44-0 [1]

10544-72-6 [2]

O; R8

T+; R26

C; R34

O; T+

R: 8-26-34

S: (1/2-)9-26-28-36/37/39-45

C ≥ 10 %: T+; R26-34

5 % ≤ C < 10 %: T; R23-34

1 % ≤ C < 5 %: T; R23-36/37/38

0,5 % ≤ C < 1 %: Xn; R20-36/37/38

0,1 % ≤ C < 0,5 %: Xn; R20

5

015-041-00-X

malathion (ISO);

1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;

[containing ≤ 0,03 % isomalathion]

204-497-7

121-75-5

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-46-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

1 % ≤ C < 25 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-100-00-X

phoxim (ISO);

α-(diethoxyphosphinothioylimino) phenylacetonitrile

238-887-3

14816-18-3

Repr. Cat. 3; R62

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-62-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-62-50/53

5 % ≤ C < 25 %: Xn, N; R43-62-50/53

1 % ≤ C < 5 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-102-00-0

tris(2-chloroethyl)phosphate

E

204-118-5

115-96-8

Carc. Cat. 3; R40

Repr. Cat. 2; R60

Xn; R22

N; R51-53

T; N

R: 60-22-40-51/53

S: 53-45-61

015-155-00-X

glufosinate ammonium (ISO);

ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate

E

278-636-5

77182-82-2

Repr. Cat. 2; R60

Repr. Cat. 3; R63

Xn; R20/21/22-48/20/22

T

R: 60-20/21/22-48/20/22-63

S: 53-45

016-009-00-8

disodium sulfide;

sodium sulfide

215-211-5

1313-82-2

T; R24

Xn; R22

C; R34

R31

N; R50

T; C; N

R: 22-24-31-34-50

S: (1/2-)26-36/37/39-45-61

017-009-00-0

ammonium perchlorate;

[containing ≥ 80 % of 0-30 μm particles]

T

232-235-1

7790-98-9

E; R3

O; R9

E

R: 3-9

S: (2-)14-16-36/37

024-004-00-7

sodium dichromate

E

234-190-3

10588-01-9

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53

O; T+; N

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61

C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53

10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53

7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53

5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53

3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53

2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53

1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53

0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53

0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53

0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43

0,1 % ≤ C < 0,2 %: T; R45-46-20

3

027-002-00-4

cobalt oxide

215-154-6

1307-96-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

027-003-00-X

cobalt sulfide

215-273-3

1317-42-6

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

028-003-00-2

nickel monoxide; [1]

nickel oxide; [2]

bunsenite [3]

E

215-215-7 [1]

234-323-5 [2]

- [3]

1313-99-1 [1]

11099-02-8 [2]

34492-97-2 [3]

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-004-00-8

nickel dioxide

E

234-823-3

12035-36-8

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-005-00-3

dinickel trioxide

E

215-217-8

1314-06-3

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-006-00-9

nickel (II) sulfide; [1]

nickel sulfide; [2]

millerite [3]

E

240-841-2 [1]

234-349-7 [2]

- [3]

16812-54-7 [1]

11113-75-0 [2]

1314-04-1 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-007-00-4

trinickel disulfide;

nickel subsulfide; [1]

heazlewoodite [2]

E

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-008-00-X

nickel dihydroxide; [1]

nickel hydroxide [2]

E

235-008-5 [1]

234-348-1 [2]

12054-48-7 [1]

11113-74-9 [2]

Carc. Cat. 1; R49

Repr. Cat. 2; R61

Muta. Cat. 3; R68

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

029-013-00-X

trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)

407-580-8

130201-51-3

Xi; R41

Xi

R: 41

S: (2-)26-39

033-005-00-1

arsenic acid and its salts with the exception of those specified elsewhere in this Annex

AE

—

—

Carc. Cat. 1; R45

T; R23/25

N; R50-53

T; N

R: 45-23/25-50/53

S: 53-45-60-61

034-002-00-8

selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex

A

—

—

T; R23/25

R33

N; R50-53

T; N

R: 23/25-33-50/53

S: (1/2-)20/21-28-45-60-61

047-001-00-2

silver nitrate

231-853-9

7761-88-8

O; R8

C; R34

N; R50-53

O; C; N

R: 8-34-50/53

S: (1/2-)26-36/37/39-45-60-61

050-002-00-0

cyhexatin (ISO);

hydroxytricyclohexylstannane;

tri(cyclohexyl)tin hydroxide

236-049-1

13121-70-5

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

C ≥ 25 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 25 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

050-003-00-6

fentin acetate (ISO);

triphenyltin acetate

212-984-0

900-95-8

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-004-00-1

fentin hydroxide (ISO);

triphenyltin hydroxide

200-990-6

76-87-9

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-008-00-3

tributyltin compounds, with the exception of those specified elsewhere in this Annex

A

—

—

T; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53

S: (1/2-)36/37/39-45-60-61

C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53

1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53

0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53

0,025 % C < 0,25 %: R52/53

1

050-011-00-X

triphenyltin compounds, with the exception of those specified elsewhere in this Annex

A

—

—

T; R23/24/25

N; R50-53

T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61

C ≥ 1 %: T, N; R23/24/25-50/53

0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

1

050-018-00-8

tin(II) methanesulphonate

401-640-7

53408-94-9

C; R34

Xn; R22

R43

N; R51-53

C; N

R: 22-34-43-51/53

S: (1/2-)22-26-36/37/39-45-61

053-003-00-4

iodoxybenzene

—

696-33-3

E; R2

E

R: 2

S: (2-)35

053-004-00-X

calcium iodoxybenzoate

C

—

—

E; R2

E

R: 2

S: (2-)35

080-001-00-0

mercury

E

231-106-7

7439-97-6

Repr. Cat. 2; R61

T+; R26

T; R48/23

N; R50-53

T+; N

R: 61-26-48/23-50/53

S: 53-45-60-61

080-010-00-X

mercury dichloride;

mercuric chloride

231-299-8

7487-94-7

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T+; R28

T; R48/24/25

C; R34

N; R50-53

T+; N

R: 28-34-48/24/25-62-68-50/53

S: (1/2-)26-36/37/39-45-60-61

092-002-00-3

uranium compounds with the exception of those specified elsewhere in this Annex

A

—

—

T+; R26/28

R33

N; R51-53

T+; N

R: 26/28-33-51/53

S: (1/2-)20/21-45-61

601-065-00-3

A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);

(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)

416-930-9

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)36/37-61

602-007-00-X

bromoform;

tribromomethane

200-854-6

75-25-2

T; R23

Xn; R22

Xi; R36/38

N; R51-53

T; N

R: 22-23-36/38-51/53

S: (1/2-)28-45-63-61

602-030-00-5

1,3-dichloropropene; [1]

(Z)-1,3-dichloropropene [2]

C D

208-826-5 [1]

233-195-8 [2]

542-75-6 [1]

10061-01-5 [2]

R10

T; R24/25

Xn; R20-65

Xi; R36/37/38

R43

N; R50-53

T; N

R: 10-20-24/25-36/37/38-43-65-50/53

S: (1/2-)36/37-45-60-61

602-054-00-6

3-iodpropene;

allyl iodide

209-130-4

556-56-9

F; R11

C; R34

F; C

R: 11-34

S: (1/2-)7-16-26-45

603-005-00-1

2-methylpropan-2-ol;

tert-butyl alcohol

200-889-7

75-65-0

F; R11

Xn; R20

Xi; R36/37

F; Xn

R: 11-20-36/37

S: (2-)9-16-46

603-018-00-2

furfuryl alcohol

202-626-1

98-00-0

Carc. Cat. 3; R40

T; R23

Xn; R21/22-48/20

Xi; R36/37

T

R: 21/22-23-36/37-40-48/20

S: (1/2-)36/37-45-63

603-023-00-X

ethylene oxide;

oxirane

E

200-849-9

75-21-8

F+; R12

R6

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T; R23

Xi; R36/37/38

F+; T

R: 45-46-6-12-23-36/37/38

S: 53-45

603-029-00-2

bis(2-chloroethyl) ether

203-870-1

111-44-4

Carc. Cat. 3; R40

T+; R26/27/28

T+

R: 26/27/28-40

S: (1/2-)7/9-27-28-36/37-45

C ≥ 7 %: T+; R26/27/28-40

1 % ≤ C < 7 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

603-037-00-6

cellulose nitrate;

nitrocellulose

T

—

—

E; R3

E

R: 3

S: (2-)35

603-046-00-5

bis(chloromethyl) ether;

oxybis(chloromethane)

E

208-832-8

542-88-1

F; R11

Carc. Cat. 1; R45

T+; R26

T; R24

Xn; R22

F; T+

R: 45-11-22-24-26

S: 53-45

C ≥ 25 %: T+; R45-22-24-26

7 % ≤ C < 25 %: T+; R45-21-26

3 % ≤ C < 7 %: T; R45-21-23

1 % ≤ C < 3 %: T; R45-23

0,1 % ≤ C < 1 %: T; R45-20

0,001 % ≤ C < 0,1 %: T; R45

603-064-00-3

1-methoxy-2-propanol;

monopropylene glycol methyl ether

203-539-1

107-98-2

R10

R67

R: 10-67

S: (2-)

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexane;

4-vinylcyclohexene diepoxide

203-437-7

106-87-6

Carc. Cat. 3; R40

T; R23/24/25

T

R: 23/24/25-40

S: (1/2-)36/37-45-63

C ≥ 1 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxane;

paraldehyde

204-639-8

123-63-7

R10

R: 10

S: (2-)29

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;

metaldehyde

203-600-2

108-62-3

F; R11

Xn; R22

F; Xn

R: 11-22

S: (2-)13-16-25-46

606-021-00-7

N-methyl-2-pyrrolidone;

1-methyl-2-pyrrolidone

212-828-1

872-50-4

Repr. Cat. 2; R61

Xi; R36/37/38

T

R: 61-36/37/38

S: 53-45

C ≥ 10 %: T; R61-36/37/38

5 % ≤ C < 10 %: T; R61

607-007-00-3

salts of oxalic acid with the exception of those specified elsewhere in this Annex

A

—

—

Xn; R21/22

Xn

R: 21/22

S: (2-)24/25

C ≥ 5 %: Xn; R21/22

607-012-00-0

benzoyl chloride

202-710-8

98-88-4

Xn; R20/21/22

C; R34

R43

C

R: 20/21/22-34-43

S: (1/2-)26-36/37/39-45

607-037-00-7

2-ethoxyethyl acetate;

ethylglycol acetate

E

203-839-2

111-15-9

R10

Repr. Cat. 2; R60-61

Xn; R20/21/22

T

R: 60-61-10-20/21/22

S: 53-45

607-051-00-3

MCPA (ISO);

4-chloro-o-tolyloxyacetic acid

202-360-6

94-74-6

Xn; R22

Xi; R38-41

N; R50-53

Xn; N

R: 22-38-41-50/53

S: (2-)26-37-39-60-61

607-052-00-9

salts and esters of MCPA

A

—

—

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

607-085-00-9

benzyl benzoate

204-402-9

120-51-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-46-61

607-095-00-3

maleic acid

203-742-5

110-16-7

Xn; R22

Xi; R36/37/38

R43

Xn

R: 22-36/37/38-43

S: (2-)24-26-28-37-46

C ≥ 25 %: Xn; R22-36/37/38-43

20 % ≤ C <25 %: Xi; R36/37/38-43

0,1 % ≤ C < 20 %: Xi; R43

607-103-00-5

succinic anhydride

203-570-0

108-30-5

Xn; R22

Xi; R36/37

Xn

R: 22-36/37

S: (2-)25-46

C ≥ 5 %: Xn; R22-36/37

1 % ≤ C < 5 %: Xi; R36/37

607-142-00-8

propyl chloroformate;

chloroformic acid propylester;

n-propyl chloroformate

203-687-7

109-61-5

F; R11

T; R23

C; R34

F; T

R: 11-23-34

S: (1/2-)16-26-36-45

607-195-00-7

2-methoxy-1-methylethyl acetate

203-603-9

108-65-6

R10

R: 10

S: (2-)

607-216-00-X

glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine

403-950-8

—

T+; R26

Xn; R22

C; R34

N; R50

T+; N

R: 22-26-34-50

S: (1/2-)26-36/37/39-38-45-61

607-231-00-1

clopyralid (ISO);

3,6-dichloropyridine-2-carboxylic acid

216-935-4

1702-17-6

Xi; R41

Xi

R: 41

S: (2-)26-39

607-245-00-8

tert-butyl acrylate

D

216-768-7

1663-39-4

F; R11

Xn; R20/21/22

Xi; R37/38

R43

N; R51-53

F; Xn; N

R: 11-20/21/22-37/38-43-51/53

S: (2-)16-25-37-61

C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53

20 % ≤ C < 25 %: Xi; R37/38-43-52/53

2,5 % ≤ C < 20 %: Xi; R43-52/53

1 % ≤ C < 2,5 %: Xi; R43

607-397-00-5

A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);

Ca phenates (branched C10-14 and C18-30 alkylated);

Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)

415-930-6

—

Repr. Cat. 3; R62

R43

Xn

R: 43-62

S: (2-)23-36/37

608-005-00-5

n-butyronitrile

203-700-6

109-74-0

F; R11

T; R23/24/25

F; T

R: 11-23/24/25

S: (1/2-)16-36/37-45-63

608-011-00-8

oxalonitrile;

cyanogen

207-306-5

460-19-5

F+; R12

T; R23

N; R50-53

F+; T; N

R: 12-23-50/53

S: (1/2-)9-16-23-33-45-63-60-61

608-044-00-8

2-cyclohexylidene-2-phenylacetonitrile

423-740-1

10461-98-0

Xn; R22

N; R51-53

Xn; N

R; 22-51/53

S: (2-)46-61

609-007-00-9

2,4-dinitrotoluene; [1]

dinitrotoluene [2]

E

204-450-0 [1]

246-836-1 [2]

121-14-2 [1]

25321-14-6 [2]

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R50-53

T; N

R: 45-23/24/25-48/22-62-68-50/53

S: 53-45-60-61

611-028-00-3

C,C′-azodi(formamide)

204-650-8

123-77-3

E; R2

R42

E; Xn

R: 2-42

S: (2-)22-24-37

611-035-00-1

tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate

403-660-1

107246-80-0

N; R51-53

N

R: 51/53

S: 61

612-044-00-3

N,N′-diacetylbenzidine

E

210-338-2

613-35-4

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/21/22

T

R: 45-20/21/22-68

S: 53-45

612-050-00-6

cyclohexylamine

203-629-0

108-91-8

R10

Repr. Cat. 3; R62

Xn; R21/22

C; R34

C

R: 10-21/22-34-62

S: (1/2-)26-36/37/39-45

C ≥ 25 %: C; R21/22-34-62

10 % ≤ C < 25 %: C; R34-62

5 % ≤ C < 10 %: Xn; R36/38-62

2 % ≤ C < 5 %: Xi; R36/38

612-076-00-8

ethyldimethylamine

209-940-8

598-56-1

F; R11

Xn; R20/22

C; R34

F; C

R: 11-20/22-34

S: (1/2-)3-16-26-36-45

612-099-00-3

4-methyl-m-phenylenediamine;

2,4-toluenediamine

E

202-453-1

95-80-7

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

R43

N; R51-53

T; N

R: 45-21-25-43-48/22-62-68-51/53

S: 53-45-61

612-101-00-2

methenamine;

hexamethylenetetramine

202-905-8

100-97-0

F; R11

R43

F; Xi

R: 11-43

S: (2-)24-37

612-151-00-5

methyl-phenylene diamine;

diaminotoluene;

[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]

E

—

—

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

Xi; R36

R43

N; R51-53

T; N

R: 45-21-25-36-43-48/22-62-68-51/53

S: 53-45-61

612-237-00-2

hydroxylammonium hydrogensulfate;

hydroxylamine sulfate(1:1); [1]

hydroxylamine phosphate; [2]

hydroxylamine dihydrogenphosphate; [3]

hydroxylamine 4-methylbenzenesulfonate [4]

T

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

E; R2

Carc. Cat. 3; R40

Xn; R21/22-48/22

Xi; R36/38

R43

N; R50

E; Xn; N

R: 21/22-36/38-40-43-48/22-50

S: (2-)36/37-61

613-116-00-7

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9

731-27-1

T+; R26

T; R48/23

Xi; R36/37/38

R43

N; R50

T+; N

R: 26-36/37/38-43-48/23-50

S: (1/2-)28-36/37/39-45-63-61

C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50

10 % ≤ C < 20 %: T+, N; R26-43-48/23-50

7 % ≤ C < 10 %: T+, N; R26-43-48/20-50

2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50

1 % ≤ C < 2,5 %: T; R23-43-48/20

0,1 % ≤ C < 1 %: Xn; R20

615-001-00-7

methyl isocyanate

210-866-3

624-83-9

F; R11

Repr. Cat. 3; R63

T+; R26

T; R24/25

R42/43

Xi; R37/38-41

F; T+

R: 11-24/25-26-37/38-41-42/43-63

S: (1/2-)16-26-27/28-36/37/39-45-63

615-004-00-3

salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

—

—

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-028-00-4

ethyl 2-(isocyanatosulfonyl)benzoate

410-220-2

77375-79-2

R14

Xn; R22-48/22

Xi; R41

R42/43

Xn

R: 14-22-41-42/43-48/22

S: (2-)8-23-26-30-35-36/37/39

615-030-00-5

alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

—

—

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-031-00-0

thallium thiocyanate

222-571-7

3535-84-0

T+; R26/28

Xn; R21

R32

R33

N; R51-53

T+; N

R: 21-26/28-32-33-51/53

S: (1/2-)13-28-36/37-45-61

615-032-00-6

metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

—

—

Xn; R20/21/22

R32

N; R50-53

Xn; N

R: 20/21/22-32-50/53

S: (2-)13-36/37-46-60-61

616-124-00-9

lithium bis(trifluoromethylsulfonyl)imide

415-300-0

90076-65-6

T; R24/25

Xn; R48/22

C; R34

R52-53

T

R: 24/25-34-48/22-52/53

S: (1/2-)22-26-36/37/39-45-61

617-017-00-X

A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;

2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene

T

412-140-3

32144-25-5

E; R2

O; R7

R53

E

R: 2-7-53

S: (2-)3/7-14-36/37/39-61

650-016-00-2

Mineral wool, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]

AQR

—

—

Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

650-017-00-8

Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]

AR

—

—

Carc. Cat. 2; R49

T

R: 49

S: 53-45

---

ANNEX 1B

| Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 003-003-00-5 | (2-methylpropyl)lithium;
  isobutyllithium | | 440-620-2 | 920-36-5 | F; R15-17
  R14
  C; R35
  R67
  N; R50-53 | F; C; N
  R: 14/15-17-35-67-50/53
  S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 | | |
| 005-013-00-5 | diethylmethoxyborane | | 425-380-9 | 7397-46-8 | F; R17
  Xn; R20/21/22-48/22
  C; R34
  R43
  R53 | F; C
  R: 17-20/21/22-34-43-48/22-53
  S: (1/2-)6-26-36/37/39-43-45-61 | | |
| 005-014-00-0 | 4-formylphenylboronic acid | | 438-670-5 | 87199-17-5 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 005-017-00-7 | sodium perborate; [1]
  perboric acid, sodium salt; [2]
  perboric acid, sodium salt, monohydrate; [3]
  sodium peroxometaborate; [4]
  perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
  sodium peroxoborate;
  [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1]
  234-390-0 [2]
  - [3]
  231-556-4 [4]
  - [5] | 15120-21-5 [1]
  11138-47-9 [2]
  12040-72-1 [3]
  7632-04-4 [4]
  10332-33-9 [5] | O; R8
  Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xn; R22
  Xi; R37-41 | O; T
  R: 61-8-22-37-41-62
  S: 53-45 | C ≥ 25 %: T; R61-22-37-41-62
  22 % ≤ C < 25 %: T; R61-37-41-62
  20 % ≤ C < 22 %: T; R61-36/37-62
  14 % ≤ C < 20 %: T; R61-36-62
  9 % ≤ C < 14 %: T; R61-62
  6,5 % ≤ C < 9 %: T; R61 | |
| 005-017-01-4 | sodium perborate; [1]
  perboric acid, sodium salt; [2]
  perboric acid, sodium salt, monohydrate; [3]
  sodium peroxometaborate; [4]
  perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
  sodium peroxoborate;
  [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1]
  234-390-0 [2]
  - [3]
  231-556-4 [4]
  - [5] | 15120-21-5 [1]
  11138-47-9 [2]
  12040-72-1 [3]
  7632-04-4 [4]
  10332-33-9 [5] | O; R8
  Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  T; R23
  Xn; R22
  Xi; R37-41 | O; T
  R: 61-8-22-23-37-41-62
  S: 53-45 | C ≥ 25 %: T; R61-22-23-37-41-62
  22 % ≤ C < 25 %: T; R61-20-37-41-62
  20 % ≤ C < 22 %: T; R61-20-36/37-62
  14 % ≤ C < 20 %: T; R61-20-36-62
  9 % ≤ C < 14 %: T; R61-20-62
  6,5 % ≤ C < 9 %: T; R61-20
  3 % ≤ C < 6,5 %: Xn; R20 | |
| 005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
  perboric acid, sodium salt, tetrahydrate; [2]
  perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
  sodium peroxoborate hexahydrate;
  [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | - [1]
  - [2]
  - [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xi; R37-41 | T
  R: 61-37-41-62
  S: 53-45-47 | C ≥ 36 %: T; R61-37-41-62
  22 % ≤ C < 36 %: T; R61-36/37-62
  20 % ≤ C < 22 %: T; R61-37-62
  14 % ≤ C < 20 %: T; R61-62
  10 % ≤ C < 14 %: T; R61 | |
| 005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
  perboric acid, sodium salt, tetrahydrate; [2]
  perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
  sodium peroxoborate hexahydrate;
  [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | - [1]
  - [2]
  - [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xn; R20
  Xi; R37-41 | T
  R: 61-20-37-41-62
  S: 53-45-47 | C ≥ 36 %: T; R61-20-37-41-62
  25 % ≤ C < 36 %: T; R61-20-36/37-62
  22 % ≤ C < 25 %: T; R61-36/37-62
  20 % ≤ C < 22 %: T; R61-37-62
  14 % ≤ C < 20 %: T; R61-62
  10 % ≤ C < 14 %: T; R61 | |
| 006-097-00-6 | 1-phenyl-3-(p-toluenesulfonyl)urea | | 424-620-1 | 13909-63-2 | Xn; R22-48/22
  R52-53 | Xn
  R: 22-48/22-52/53
  S: (2-)22-36-61 | | |
| 006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | | 429-170-8 | 134575-17-0 | Xn; R22-48/22
  Xi; R41
  R43 | Xn
  R: 22-41-43-48/22
  S: (2-)22-26-36/37/39 | | |
| 006-099-00-7 | N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;
  3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate | | 432-520-2 | 232938-43-1 | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 006-101-00-6 | mixture of: N,N′′-(methylenedi-4,1-phenylene)bis[N′-phenylurea];

  N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;

  N,N′′-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea] | | 423-070-8 | — | R53 | R: 53
  S: 61 | | |
| 006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamate | E | 432-750-3 | — | Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Xn; R22-48/22
  R43
  N; R51-53 | T; N
  R: 45-46-22-43-48/22-51/53
  S: 53-45-61 | | |
| 006-103-00-7 | N,N′′-(methylenedi-4,1-phenylene)bis[N′-octyl]urea | | 445-760-8 | — | Xi; R41
  R42
  N; R50-53 | Xn; N
  R: 41-42-50/53
  S: (2-)22-26-39-45-60-61 | C ≥10 %: Xn, N; R41-42-50/53
  5 % ≤ C < 10 %: Xn, N; R36-42-50/53
  1 % ≤ C < 5 %: Xn, N; R42-50/53
  0,25 % ≤ C < 1 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 ≤ C < 0,025 %: R52/53 | |
| 007-029-00-8 | diethyldimethylammonium hydroxide | | 419-400-5 | 95500-19-9 | Xn; R21/22
  C; R35 | C
  R: 21/22-35
  S: (1/2-)26-36/37/39-45 | | |
| 012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | | 422-150-1 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | | 405-020-7 | 105024-66-6 | Repr.Cat.2; R60
  N; R50-53 | T; N
  R: 60-50/53
  S: 53-45-60-61 | C ≥ 0,5 %: T, N; R60-50/53
  0,025 % ≤ C < 0,5 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 014-037-00-5 | 2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime | | 433-360-6 | 34036-80-1 | Xn; R48/22
  R43
  R52-53 | Xn
  R: 43-48/22-52/53
  S: (2-)36/37-61 | | |
| 014-038-00-0 | S-(3-(triethoxysilyl)propyl)octanethioate | | 436-690-9 | 220727-26-4 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | | 439-360-2 | 142877-45-0 | Xi; R38-41
  R52-53 | Xi
  R: 38-41-52/53
  S: (2-)26-37/39-61 | | |
| 014-041-00-7 | N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane | | 445-890-5 | 201290-01-9 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)24-37 | | |
| 014-042-00-2 | mixture of: O,O′,O′′,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | | 423-010-0 | — | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | | 432-200-2 | — | F; R11
  Xi; R37/38-41
  R52-53 | F; Xi
  R: 11-37/38-41-52/53
  S: (2-)6-26-36/39-61 | | |
| 014-044-00-3 | 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane | | 433-050-0 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 014-045-00-9 | magnesium sodium fluoride silicate | | 442-650-1 | — | Xn; R48/20 | Xn
  R: 48/20
  S: (2-)22-36 | | |
| 015-190-00-0 | bis(2,4-dicumylphenyl) neopentyl diphosphite;
  3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | | 421-920-2 | 154862-43-8 | R53 | R: 53
  S: 61 | | |
| 015-191-00-6 | dodecyldiphenyl phosphate | | 431-760-5 | 27460-02-2 | Xi; R38
  R52-53 | Xi
  R: 38-52/53
  S: (2-)37-61 | | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | | 432-770-2 | 139189-30-3 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) | | 442-960-7 | 332350-93-3 | T; R25
  Xi; R41
  N; R50-53 | T; N
  R: 25-41-50/53
  S: (1/2-)26-39-45-60-61 | | |
| 015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | | 444-440-5 | 220689-12-3 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)61 | | |
| 015-195-00-8 | mixture of: potassium o-toluenephosphonate;
  potassium m-toluenephosphonate;
  potassium p-toluenephosphonate | | 433-860-4 | — | Xi; R36
  R43
  R52-53 | Xi
  R: 36-43-52/53
  S: (2-)24-26-37-61 | | |
| 015-196-00-3 | mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
  diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
  methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate | | 435-960-3 | — | Carc.Cat.2; R45
  Muta.Cat.2; R46
  R43 | T
  R: 45-46-43
  S: 53-45 | | |
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | | 420-160-9 | 107667-02-7 | R10
  T; R23
  Xn; R22
  C; R34
  N; R51-53 | T; N
  R: 10-22-23-34-51/53
  S: (1/2-)9-26-36/37/39-45-61 | | |
| 015-198-00-4 | (4-phenylbutyl)phosphinic acid | | 420-450-5 | 86552-32-1 | Carc.Cat.3; R40
  Xi; R41 | Xn
  R: 40-41
  S: (2-)23-26-36/37/39 | | |
| 016-094-00-1 | sulfur | | 231-722-6 | 7704-34-9 | Xi; R38 | Xi
  R: 38
  S: (2-)46 | | |
| 016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | | 434-480-1 | 32047-53-3 | Xn; R22
  C; R34
  R43
  R52-53 | C
  R: 22-34-43-52/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 017-009-01-8 | ammonium perchlorate;
  [containing < 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R2
  O; R9 | E
  R: 2-9
  S: (2-)14-16-36/37 | | |
| 022-004-00-1 | potassium titanium oxide (K2Ti6O13) | | 432-240-0 | 12056-51-8 | Carc.Cat.3; R40 | Xn
  R: 40
  S: (2-)22-36/37 | | |
| 022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium | | 419-840-8 | 169104-71-6 | F; R11
  C; R34
  R43
  R53 | F; C
  R: 11-34-43-53
  S: (1/2-)6-9-16-26-36/37/39-45-61 | | |
| 028-002-01-4 | nickel powder;
  [particle diameter < 1 mm] | | 231-111-4 | 7440-02-0 | Carc. Cat. 3; R40
  T; R48/23
  R43
  R52-53 | T
  R: 40-43-48/23-52/53
  S: (2-)36/37/39-45-61 | | |
| 028-013-00-7 | nickel matte | E, H | 273-749-6 | 69012-50-6 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | E | 295-859-3 | 92129-57-2 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  Xi; R38
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-38-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53
  20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53
  2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | E, H | 305-433-1 | 94551-87-8 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 1; R61
  Repr. Cat. 3; R62
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-62-68-50/53
  S: 53-45-60-61 | | |
| 028-016-00-3 | nickel diperchlorate;
  perchloric acid, nickel(II) salt | E, H | 237-124-1 | 13637-71-3 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  C; R34
  R42/43
  N; R50-53 | T; N
  R: 49-61-34-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53
  5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53
  2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-017-00-9 | nickel dipotassium bis(sulfate); [1]
  diammonium nickel bis(sulfate) [2] | E, H | 237-563-9 [1]
  239-793-2 [2] | 13842-46-1 [1]
  15699-18-0 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-018-00-4 | nickel bis(sulfamidate);
  nickel sulfamate | E, H | 237-396-1 | 13770-89-3 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-019-00-X | nickel bis(tetrafluoroborate) | E, H | 238-753-4 | 14708-14-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-021-00-0 | nickel diformate; [1]
  formic acid, nickel salt; [2]
  formic acid, copper nickel salt [3] | E, H | 222-101-0 [1]
  239-946-6 [2]
  268-755-0 [3] | 3349-06-2 [1]
  15843-02-4 [2]
  68134-59-8 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-022-00-6 | nickel di(acetate); [1]
  nickel acetate [2] | E, H | 206-761-7 [1]
  239-086-1 [2] | 373-02-4 [1]
  14998-37-9 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-024-00-7 | nickel dibenzoate | E, H | 209-046-8 | 553-71-9 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | E, H | 223-463-2 | 3906-55-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-026-00-8 | nickel(II) stearate;
  nickel(II) octadecanoate | E, H | 218-744-1 | 2223-95-2 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-027-00-3 | nickel dilactate | E, H | — | 16039-61-5 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-028-00-9 | nickel(II) octanoate | E, H | 225-656-7 | 4995-91-9 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat 2; R61
  T; R48/23
  C; R35
  R42/43
  N; R50-53 | T; C; N
  R: 49-61-35-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53
  10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53
  5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53
  2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-029-00-4 | nickel difluoride; [1]
  nickel dibromide; [2]
  nickel diiodide; [3]
  nickel potassium fluoride [4] | E, H | 233-071-3 [1]
  236-665-0 [2]
  236-666-6 [3]
  - [4] | 10028-18-9 [1]
  13462-88-9 [2]
  13462-90-3 [3]
  11132-10-8 [4] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-030-00-X | nickel hexafluorosilicate | E, H | 247-430-7 | 26043-11-8 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-031-00-5 | nickel selenate | E, H | 239-125-2 | 15060-62-5 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-032-00-0 | nickel hydrogen phosphate; [1]
  nickel bis(dihydrogen phosphate); [2]
  trinickel bis(orthophosphate); [3]
  dinickel diphosphate; [4]
  nickel bis(phosphinate); [5]
  nickel phosphinate; [6]
  phosphoric acid, calcium nickel salt; [7]
  diphosphoric acid, nickel(II) salt [8] | E, H | 238-278-2 [1]
  242-522-3 [2]
  233-844-5 [3]
  238-426-6 [4]
  238-511-8 [5]
  252-840-4 [6]
  - [7]
  - [8] | 14332-34-4 [1]
  18718-11-1 [2]
  10381-36-9 [3]
  14448-18-1 [4]
  14507-36-9 [5]
  36026-88-7 [6]
  17169-61-8 [7]
  19372-20-4 [8] | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-033-00-6 | diammonium nickel hexacyanoferrate | E, H | — | 74195-78-1 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-034-00-1 | nickel dicyanide | E, H | 209-160-8 | 557-19-7 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  R32
  N; R50-53 | T; N
  R: 49-32-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-035-00-7 | nickel chromate | E, H | 238-766-5 | 14721-18-7 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-036-00-2 | nickel(II) silicate; [1]
  dinickel orthosilicate; [2]
  nickel silicate (3:4); [3]
  silicic acid, nickel salt; [4]
  trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] | E, H | 244-578-4 [1]
  237-411-1 [2]
  250-788-7 [3]
  253-461-7 [4]
  235-688-3 [5] | 21784-78-1 [1]
  13775-54-7 [2]
  31748-25-1 [3]
  37321-15-6 [4]
  12519-85-6 [5] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-037-00-8 | dinickel hexacyanoferrate | E, H | 238-946-3 | 14874-78-3 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-038-00-3 | trinickel bis(arsenate);
  nickel(II) arsenate | E, H | 236-771-7 | 13477-70-8 | Carc. Cat. 1; R45
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 45-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-039-00-9 | nickel oxalate; [1]
  oxalic acid, nickel salt [2] | E, H | 208-933-7 [1]
  243-867-2 [2] | 547-67-1 [1]
  20543-06-0 [2] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N: R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-040-00-4 | nickel telluride | E, H | 235-260-6 | 12142-88-0 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-041-00-X | trinickel tetrasulfide | E, H | — | 12137-12-1 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-042-00-5 | trinickel bis(arsenite) | E, H | — | 74646-29-0 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-043-00-0 | cobalt nickel gray periclase;
  C.I. Pigment Black 25;
  C.I. 77332; [1]
  cobalt nickel dioxide; [2]
  cobalt nickel oxide [3] | E, H | 269-051-6 [1]
  261-346-8 [2]
  - [3] | 68186-89-0 [1]
  58591-45-0 [2]
  12737-30-3 [3] | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-044-00-6 | nickel tin trioxide;
  nickel stannate | E, H | 234-824-9 | 12035-38-0 | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-045-00-1 | nickel triuranium decaoxide | E, H | 239-876-6 | 15780-33-3 | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-046-00-7 | nickel dithiocyanate | E, H | 237-205-1 | 13689-92-4 | Carc. Cat. 1; R49
  Muta. Cat. 3;R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  R32
  N; R50-53 | T; N
  R: 49-61-32-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-047-00-2 | nickel dichromate | E, H | 239-646-5 | 15586-38-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1% ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-048-00-8 | nickel(II) selenite | E, H | 233-263-7 | 10101-96-9 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-049-00-3 | nickel selenide | E, H | 215-216-2 | 1314-05-2 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-050-00-9 | silicic acid, lead nickel salt | E, H | — | 68130-19-8 | Carc. Cat. 1: R49
  Repr. Cat. 1: R61
  Repr. Cat. 3; R62
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-61-43-48/23-62-50/53
  S: 53-45-60-61 | | |
| 028-051-00-4 | nickel diarsenide; [1]
  nickel arsenide [2] | E, H | 235-103-1 [1]
  248-169-1 [2] | 12068-61-0 [1]
  27016-75-7 [2] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-052-00-X | nickel barium titanium primrose priderite;
  C.I. Pigment Yellow 157;
  C.I. 77900 | E, H | 271-853-6 | 68610-24-2 | Carc. Cat. 1: R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-053-00-5 | nickel dichlorate; [1]
  nickel dibromate; [2]
  ethyl hydrogen sulfate, nickel(II) salt [3] | E, H | 267-897-0 [1]
  238-596-1 [2]
  275-897-7 [3] | 67952-43-6 [1]
  14550-87-9 [2]
  71720-48-4 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T: R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-054-00-0 | nickel(II) trifluoroacetate; [1]
  nickel(II) propionate; [2]
  nickel bis(benzenesulfonate); [3]
  nickel(II) hydrogen citrate; [4]
  citric acid, ammonium nickel salt; [5]
  citric acid, nickel salt; [6]
  nickel bis(2-ethylhexanoate); [7]
  2-ethylhexanoic acid, nickel salt; [8]
  dimethylhexanoic acid nickel salt; [9]
  nickel(II) isooctanoate; [10]
  nickel isooctanoate; [11]
  nickel bis(isononanoate); [12]
  nickel(II) neononanoate; [13]
  nickel(II) isodecanoate; [14]
  nickel(II) neodecanoate; [15]
  neodecanoic acid, nickel salt; [16]
  nickel(II) neoundecanoate; [17]
  bis(D-gluconato-O
  1,O
  2)nickel; [18]
  nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
  nickel(II) palmitate; [20]
  (2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
  (isononanoato-O)(isooctanoato-O)nickel; [22]
  (isooctanoato-O)(neodecanoato-O)nickel; [23]
  (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
  (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
  (isodecanoato-O)(isooctanoato-O)nickel; [26]
  (isodecanoato-O)(isononanoato-O)nickel; [27]
  (isononanoato-O)(neodecanoato-O)nickel; [28]
  fatty acids, C6-19-branched, nickel salts; [29]
  fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
  2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] | E, H | 240-235-8 [1]
  222-102-6 [2]
  254-642-3 [3]
  242-533-3 [4]
  242-161-1 [5]
  245-119-0 [6]
  224-699-9 [7]
  231-480-1 [8]
  301-323-2 [9]
  249-555-2 [10]
  248-585-3 [11]
  284-349-6 [12]
  300-094-6 [13]
  287-468-1 [14]
  287-469-7 [15]
  257-447-1 [16]
  300-093-0 [17]
  276-205-6 [18]
  258-051-1 [19]
  237-138-8 [20]
  287-470-2 [21]
  287-471-8 [22]
  284-347-5 [23]
  284-351-7 [24]
  285-698-7 [25]
  285-909-2 [26]
  284-348-0 [27]
  287-592-6 [28]
  294-302-1 [29]
  283-972-0 [30]
  - [31] | 16083-14-0 [1]
  3349-08-4 [2]
  39819-65-3 [3]
  18721-51-2 [4]
  18283-82-4 [5]
  22605-92-1 [6]
  4454-16-4 [7]
  7580-31-6 [8]
  93983-68-7 [9]
  29317-63-3 [10]
  27637-46-3 [11]
  84852-37-9 [12]
  93920-10-6 [13]
  85508-43-6 [14]
  85508-44-7 [15]
  51818-56-5 [16]
  93920-09-3 [17]
  71957-07-8 [18]
  52625-25-9 [19]
  13654-40-5 [20]
  85508-45-8 [21]
  85508-46-9 [22]
  84852-35-7 [23]
  84852-39-1 [24]
  85135-77-9 [25]
  85166-19-4 [26]
  84852-36-8 [27]
  85551-28-6 [28]
  91697-41-5 [29]
  84776-45-4 [30]
  72319-19-8 [31] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-055-00-6 | nickel(II) sulfite; [1]
  nickel tellurium trioxide; [2]
  nickel tellurium tetraoxide; [3]
  molybdenum nickel hydroxide oxide phosphate [4] | E, H | 231-827-7 [1]
  239-967-0 [2]
  239-974-9 [3]
  268-585-7 [4] | 7757-95-1 [1]
  15851-52-2 [2]
  15852-21-8 [3]
  68130-36-9 [4] | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-056-00-1 | nickel boride (NiB); [1]
  dinickel boride; [2]
  trinickel boride; [3]
  nickel boride; [4]
  dinickel silicide; [5]
  nickel disilicide; [6]
  dinickel phosphide; [7]
  nickel boron phosphide [8] | E, H | 234-493-0 [1]
  234-494-6 [2]
  234-495-1 [3]
  235-723-2 [4]
  235-033-1 [5]
  235-379-3 [6]
  234-828-0 [7]
  - [8] | 12007-00-0 [1]
  12007-01-1 [2]
  12007-02-2 [3]
  12619-90-8 [4]
  12059-14-2 [5]
  12201-89-7 [6]
  12035-64-2 [7]
  65229-23-4 [8] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-057-00-7 | dialuminium nickel tetraoxide; [1]
  nickel titanium trioxide; [2]
  nickel titanium oxide; [3]
  nickel divanadium hexaoxide; [4]
  cobalt dimolybdenum nickel octaoxide; [5]
  nickel zirkonium trioxide; [6]
  molybdenum nickel tetraoxide; [7]
  nickel tungsten tetraoxide; [8]
  olivine, nickel green; [9]
  lithium nickel dioxide; [10]
  molybdenum nickel oxide; [11] | E, H | 234-454-8 [1]
  234-825-4 [2]
  235-752-0 [3]
  257-970-5 [4]
  268-169-5 [5]
  274-755-1 [6]
  238-034-5 [7]
  238-032-4 [8]
  271-112-7 [9]
  - [10]
  - [11] | 12004-35-2 [1]
  12035-39-1 [2]
  12653-76-8 [3]
  52502-12-2 [4]
  68016-03-5 [5]
  70692-93-2 [6]
  14177-55-0 [7]
  14177-51-6 [8]
  68515-84-4 [9]
  12031-65-1 [10]
  12673-58-4 [11] | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-058-00-2 | cobalt lithium nickel oxide | E | 442-750-5 | — | Carc. Cat. 1; R49
  T+; R26
  T; R48/23
  R43
  N; R50-53 | T+; N
  R: 49-26-43-48/23-50/53
  S: 53-45-60-61 | | |
| 029-014-00-5 | mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;
  2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex | | 419-610-7 | 171866-24-3 | Xn; R48/22
  N; R51-53 | Xn; N
  R: 48/22-51/53
  S: (2-)22-36-61 | | |
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | | 423-570-6 | 169314-88-9 | R52-53 | R: 52/53
  S: 61 | | |
| 030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | | 440-060-9 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 042-005-00-0 | mixture of: mono- and di-glycerols of canola oil;
  canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

  N,N-diorgano dithiocarbamate molybdenum complex | | 434-240-6 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 050-023-00-5 | mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
  bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
  bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
  ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane | | 422-920-5 | — | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)23-36-60-61 | C ≥ 10 %: Xn, N; R48/22-50/53
  2,5 % ≤ C < 10 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 050-024-00-0 | mixture of: tri-p-tolyltin hydroxide;
  hexa-p-tolyl-distannoxane | | 432-230-6 | — | T; R48/25
  Xn; R22
  Xi; R38-41
  R43
  N; R50-53 | T; N
  R: 22-38-41-43-48/25-50/53
  S: (1/2-)22-26-36/37/39-45-60-61 | | |
| 064-001-00-8 | gadolinium(III)sulfite trihydrate | | 456-900-2 | 51285-81-5 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 078-011-00-5 | hydroxydisulfito platinum(II) acid | | 423-310-1 | 61420-92-6 | Xn; R22-48/20/21/22
  C; R35
  R42/43
  R52-53 | C
  R: 22-35-42/43-48/20/21/22-52/53
  S: (1/2-)23-24-26-28-36/37/39-45-61 | | |
| 078-012-00-0 | platinum(IV) nitrate/nitric acid solution | | 432-400-1 | — | C; R35
  N; R50-53 | C; N
  R: 35-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | | 431-780-4 | 199876-46-5 | Xn; R22-48/22
  N; R51-53 | Xn; N
  R: 22-48/22-51/53
  S: (2-)22-36-61 | | |
| 601-080-00-5 | mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;
  1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
  1-(sec-butylphenyl-1-phenylethane, mixed isomers | | 431-100-6 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 601-081-00-0 | cyclohexadeca-1,9-diene | | 431-730-1 | 4277-06-9 | Xi; R38
  R43
  R53 | Xi
  R: 38-43-53
  S: (2-)36/37-61 | | |
| 601-082-00-6 | mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
  exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane | | 434-420-4 | — | Xi; R38-41
  N; R50-53 | Xi; N
  R: 38-41-50/53
  S: (2-)23-26-37/39-57-60-61 | | |
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | | 435-000-3 | 22094-83-3 | Xn; R65
  Xi; R38
  R53 | Xn
  R: 38-65-53
  S: (2-)37-62-61 | | |
| 601-084-00-7 | mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
  5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) | | 435-180-3 | — | Xn; R65
  Xi; R38
  N; R50-53 | Xn; N
  R: 38-65-50/53
  S: (2-)37-62-60-61 | | |
| 602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | | 422-100-7 | 102061-82-5 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 602-106-00-8 | 2-bromo-4,6-difluoroaniline | | 429-430-0 | 444-14-4 | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)25-61 | | |
| 602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | | 439-500-2 | 33831-83-3 | Xn; R22
  Xi; R38
  N; R51-53 | Xn; N
  R: 22-38-51/53
  S: (2-)37-61 | | |
| 602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | | 443-840-7 | 4084-38-2 | Xn; R22
  Xi; R36
  R43 | Xn
  R: 22-36-43
  S: (2-)26-36/37 | | |
| 603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride ... %;
  glycidyl trimethylammonium chloride ... % | B E | 221-221-0 | 3033-77-0 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  Xn; R21/22-48/22
  Xi; R41
  R43
  R52-53 | T
  R: 45-21/22-41-43-48/22-62-68-52/53
  S: 53-45-61 | | |
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
  galaxolide;
  (HHCB) | | 214-946-9 | 1222-05-5 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 603-213-00-2 | 2-methoxy-2-methylbutane;

  tert-amyl methyl ether | | 213-611-4 | 994-05-8 | F; R11
  Xn; R22
  R67 | F; Xn
  R: 11-22-67
  S: (2-)9-16-23-33 | | |
| 603-214-00-8 | 1,1-diisopropoxycyclohexane | | 413-740-8 | 1132-95-2 | C; R34 | C
  R: 34
  S: (1/2-)23-26-36/37/39-45 | | |
| 603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | | 418-330-2 | 162241-33-0 | E; R2
  Xn; R22-48/22
  Xi; R41
  R43
  N; R50-53 | E; Xn; N
  R: 2-22-41-43-48/22-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | | 422-660-2 | 7480-35-5 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)24-26-37/39-61 | | |
| 603-217-00-4 | 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | | 423-560-1 | 161717-32-4 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37/39-61 | | |
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | | 432-890-5 | 72955-94-3 | R53 | R: 53
  S: 61 | | |
| 603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
  [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] | | 433-580-2 | 214353-17-0 | Xn; R22
  C; R34
  N; R51-53 | C; N
  R: 22-34-51/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
  [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] | E | 433-580-2 | 214353-17-0 | Carc. Cat. 2; R45
  Xn; R22
  C; R34
  N; R51-53 | T; N
  R: 45-22-34-51/53
  S: 53-45-61 | | |
| 603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | | 433-820-6 | 118058-74-5 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 603-223-00-7 | 2-cyclopentylidene cyclopentanol;
  1,1′-bi(cyclopentyliden)-2-ol | | 434-270-1 | 6261-30-9 | Xi; R38-41
  R52-53 | Xi
  R: 38-41-52/53
  S: (2-)26-37/39-61 | | |
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | | 435-790-1 | 297730-93-9 | R53 | R: 53
  S: 61 | | |
| 603-225-00-8 | erythromycin A9-oxime (E);
  (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) | | 437-070-0 | 13127-18-9 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 603-226-00-3 | 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | | 444-500-0 | 1440-00-2 | R52-53 | R: 52/53
  S: 61 | | |
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
  reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate | | 445-060-2 | 203574-04-3 | O; R7
  N; R50-53 | O; N
  R: 7-50/53
  S: (2-)3/7-14-36/37/39-60-61 | | |
| 603-228-00-4 | (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
  6-fluoro-2-(2-oxiranyl)chromane | | 419-620-1 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)36/37-61 | | |
| 603-229-00-X | sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | | 420-800-7 | — | Xi; R38-41
  R43
  N; R50-53 | Xi; N
  R: 38-41-43-50/53
  S: (2-)24-26-37/39-60-61 | | |
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | | 440-030-5 | — | Xi; R38-41
  R53 | Xi
  R: 38-41-53
  S: (2-)26-37/39-61 | | |
| 603-231-00-0 | (S)-1,1-diphenyl-1,2-propanediol | | 443-220-6 | — | R52-53 | R: 52/53
  S: 22-61 | | |
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | | 444-420-6 | — | R53 | R: 53
  S: 61 | | |
| 603-233-00-1 | mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
  4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
  1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
  1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
  (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
  (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | | 444-430-0 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | | 444-480-3 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)37-61 | | |
| 604-074-00-0 | tetrabromobisphenol-A;
  2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol | | 201-236-9 | 79-94-7 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol;
  4-tert-octylphenol | | 205-426-2 | 140-66-9 | Xi; R38-41
  N; R50-53 | Xi; N
  R: 38-41-50/53
  S: (2-)26-37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-50/53
  10 % ≤ C < 20 %: Xi, N; R41-50/53
  5 % ≤ C < 10 %: Xi, N; R36-50/53
  2,5 % ≤ C < 5 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 604-076-00-1 | phenolphthalein | | 201-004-7 | 77-09-8 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62 | T
  R: 45-62-68
  S: 53-45 | C ≥ 5 %: T; R45-62-68
  1 % ≤ C < 5 %: T; R45-68 | |
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | | 419-750-9 | 98809-58-6 | R53 | R: 53
  S: 61 | | |
| 604-079-00-8 | 4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | | 428-970-4 | 13595-25-0 | Repr.Cat.3; R62
  R43
  N; R51-53 | Xn; N
  R: 43-62-51/53
  S: (2-)22-36/37-61 | | |
| 604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | | 432-560-0 | 61721-07-1 | Xn; R20
  C; R35
  R43
  N; R51-53 | C; N
  R: 20-35-43-51/53
  S: (1/2-)26-28-36/37/39-45-61 | | |
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | | 433-130-5 | 1571-75-1 | N; R50-53 | N
  R: 50/53
  S: 25-60-61 | | |
| 604-082-00-4 | 2-chloro-6-fluoro-phenol | E | 433-890-8 | 2040-90-6 | Muta.Cat.2; R46
  Repr.Cat.3; R62
  Xn; R22
  C; R34
  R43
  N; R51-53 | T; N
  R: 46-22-34-43-62-51/53
  S: 53-45-61 | | |
| 604-083-00-X | 4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol | | 439-270-3 | 260408-02-4 | R53 | R: 53
  S: 61 | | |
| 604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | | 441-000-4 | 121219-07-6 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)23-61 | | |
| 604-087-00-1 | mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
  1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
  1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol | | 433-640-8 | — | F; R17
  R44
  R53 | F
  R: 17-44-53
  S: (2-)15-22-61 | | |
| 604-089-00-2 | 2-methyl-5-tert-butylthiophenol | | 444-970-7 | — | R10
  Repr.Cat.3; R63
  Xn; R48/20/22-65
  Xi; R36/38
  R43
  R67
  N; R50-53 | Xn; N
  R: 10-36/38-43-48/20/22-63-65-67-50/53
  S: (2-)26-36/37-62-60-61 | | |
| 605-037-00-1 | trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
  3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde | | 421-800-1 | 120578-03-2 | R53 | R: 53
  S: 22-61 | | |
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | | 433-900-0 | 55066-49-4 | Xn; R22
  Xi; R38
  R43
  N; R51-53 | Xn; N
  R: 22-38-43-51/53
  S: (2-)36/37-61 | | |
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | | 441-810-8 | 116313-85-0 | Xn; R22
  Xi; R41
  R43 | Xn
  R: 22-41-43
  S: (2-)22-24-26-37/39 | | |
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | | 421-080-7 | 161462-35-7 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)36-60-61 | | |
| 606-125-00-2 | 1-benzylimidazolidine-2,4-dione | | 421-340-1 | 6777-05-5 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | | 421-470-7 | 99788-75-7 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 606-128-00-9 | 2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | | 422-650-8 | 148935-94-8 | R53 | R: 53
  S: 61 | | |
| 606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
  (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | | 423-090-7 | 156732-13-7 | R53 | R: 53
  S: 61 | | |
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | | 423-860-2 | 56309-94-5 | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-61 | | |
| 606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | E | 427-230-8 | 5571-36-8 | Repr. Cat. 2; R60
  Xn; R48/22
  N; R51-53 | T; N
  R: 60-48/22-51/53
  S: 53-45-61 | | |
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | | 433-490-3 | 6563-83-3 | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-61 | | |
| 606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | | 433-560-3 | 15375-21-0 | Repr. Cat.3; R62 | Xn
  R: 62
  S: (2-)22-36/37 | | |
| 606-135-00-7 | cyclohexadecanone | | 438-930-8 | 2550-52-9 | R53 | R: 53
  S: 61 | | |
| 606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | | 444-350-6 | 133413-70-4 | Xi; R36
  R53 | Xi
  R: 36-53
  S: (2-)26-61 | | |
| 606-137-00-8 | trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione | | 444-750-0 | 211387-26-7 | R53 | R: 53
  S: 22-61 | | |
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | | 444-800-1 | 141645-23-0 | R10
  Xn; R22-48/22
  Xi; R38-41
  R43
  N; R50-53 | Xn; N
  R: 10-22-38-41-43-48/22-50/53
  S: (2-)23-26-36/37/39-60-61 | C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53
  20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53
  10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 606-139-00-9 | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | | 444-830-5 | 124379-29-9 | R53 | R: 53
  S: 61 | | |
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | | 444-860-9 | 474510-57-1 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)22-36-60-61 | | |
| 606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | | 418-410-7 | — | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 606-142-00-5 | mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
  (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
  (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | | 434-290-9 | — | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)61 | | |
| 607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | | 422-360-1 | 100491-29-0 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)22-24-37-61 | | |
| 607-618-00-5 | menadione sodium bisulfite;
  2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | | 204-987-0 | 130-37-0 | Xi; R36/38
  N; R50-53 | Xi; N
  R: 36/38-50/53
  S: (2-)24/25-60-61 | | |
| 607-619-00-0 | menadione nicotinamide bisulfite;
  1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | | 277-543-7 | 73581-79-0 | Xi; R36/38
  N; R50-53 | Xi; N
  R: 36/38-50/53
  S: (2-)24/25-60-61 | | |
| 607-620-00-6 | trisodium nitrilotriacetate | | 225-768-6 | 5064-31-3 | Carc. Cat. 3; R40
  Xn; R22
  Xi; R36 | Xn
  R: 22-36-40
  S: (2-)26-36/37-46 | C ≥ 25 %: Xn; R22-36-40
  20 ≤ % C < 25 %: Xn; R36-40
  5 ≤ % C < 20 %: Xn; R40 | |
| 607-621-00-1 | milbemectin (ISO);
  [mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | | — | — | Xn; R20/22
  N; R50-53 | Xn; N
  R: 20/22-50/53
  S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R20/22-50/53
  0,25 % ≤ C < 25 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | |
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | | 231-057-1 | 7425-14-1 | Repr. Cat. 3; R63 | Xn
  R: 63
  S: (2-)36/37 | | |
| 607-623-00-2 | diisobutyl phthalate | | 201-553-2 | 84-69-5 | Repr. Cat. 2; R61
  Repr. Cat. 3; R62 | T
  R: 61-62
  S: 53-45 | C ≥ 25 %: T; R61-62
  5 % ≤ C < 25 %: Xn; R62 | |
| 607-624-00-8 | perfluorooctane sulfonic acid;
  heptadecafluorooctane-1-sulfonic acid; [1]
  potassium perfluorooctanesulfonate;
  potassium heptadecafluorooctane-1-sulfonate; [2]
  diethanolamine perfluorooctane sulfonate; [3]
  ammonium perfluorooctane sulfonate;
  ammonium heptadecafluorooctanesulfonate; [4]
  lithium perfluorooctane sulfonate;
  lithium heptadecafluorooctanesulfonate [5] | E | 217-179-8 [1]
  220-527-1 [2]
  274-460-8 [3]
  249-415-0 [4]
  249-644-6 [5] | 1763-23-1 [1]
  2795-39-3 [2]
  70225-14-8 [3]
  29081-56-9 [4]
  29457-72-5 [5] | Carc. Cat. 3; R40
  Repr. Cat. 2; R61
  T; R48/25
  Xn; R20/22
  R64
  N; R51-53 | T; N
  R: 61-20/22-40-48/25-64-51/53
  S: 53-45-61 | | |
| 607-625-00-3 | clodinafop-propargyl (ISO) | | — | 105512-06-9 | Xn; R22-48/22
  R43
  N; R50-53. | Xn; N
  R: 22-43-48/22-50/53
  S: (2-)24-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-48/22-50/53
  10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53
  2,5 % ≤ C < 10 %: Xi, N; R43-51/53
  0,25 % ≤ C < 2,5 %: Xi; R43-52/53
  0,001 % ≤ C < 0,25 %: Xi; R43 | |
| 607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | | 401-290-5 | 103112-35-2 | Carc.Cat.2; R45
  N; R50-53 | T; N
  R: 45-50/53
  S: 53-45-60-61 | | |
| 607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | | 416-360-0 | 162221-28-5 | R43 | Xi
  R: 43
  S: (2-)22-24-37 | | |
| 607-628-00-X | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | | 419-240-6 | 171054-89-0 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | | 419-270-1 | 123599-82-6 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | | 419-560-6 | 4369-14-6 | Xn; R20
  C; R34
  R43
  R52-53 | C
  R: 20-34-43-52/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 607-631-00-6 | mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
  (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | | 442-300-8 | — | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | | 420-210-1 | 111244-14-5 | R53 | R: 53
  S: 61 | | |
| 607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | | 440-480-2 | 341026-59-3 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-24-26-37/39 | | |
| 607-634-00-2 | (S)-(-)-2-acetoxypropionylchloride;
  (1S)-2-chloro-1-methyl-2-oxoethyl acetate | | 420-610-4 | 36394-75-9 | Xn; R22
  C; R34
  R43 | C
  R: 22-34-43
  S: (1/2-)23-26-36/37/39-45 | | |
| 607-635-00-8 | trisodium N-(3-propionato)-L-aspartate | | 422-090-4 | 172737-80-3 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-636-00-3 | 1-bromo-2-methylpropyl propionate | | 422-900-6 | 158894-67-8 | R10
  Carc.Cat.3; R40
  C; R34
  R43 | C
  R: 10-34-40-43
  S: (1/2-)7/9-8-23-26-36/37/39-45 | | |
| 607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | | 423-730-5 | 250688-43-8 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | | 431-090-3 | 190085-41-7 | R53 | R: 53
  S: 61 | | |
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | | 431-770-1 | 216698-07-6 | R53 | R: 53
  S: 61 | | |
| 607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid;
  2-formamido-3-thiophenecarboxylic acid | | 431-930-9 | 43028-69-9 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)22-24-37 | | |
| 607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | | 432-210-7 | 141631-22-3 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 607-643-00-1 | dimethyl (2S)-2-hydroxysuccinate | | 432-310-0 | 617-55-0 | R10
  Xi; R41
  R43 | Xi
  R: 10-41-43
  S: (2-)24-26-37/39-43 | | |
| 607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | | 432-350-9 | 81752-87-6 | Xi; R38 | Xi
  R: 38
  S: (2-)37 | | |
| 607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | | 432-550-6 | 243858-01-7 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-646-00-8 | D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

  tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | | 432-960-5 | 124655-09-0 | Xn; R22 | Xn
  R: 22
  S: (2-)25 | | |
| 607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane | | 433-530-1 | 143446-73-5 | Xn; R22
  R43
  N; R50 | Xn; N
  R: 22-43-50
  S: (2-)24-37-57-61 | | |
| 607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | | 433-690-0 | 167678-46-8 | C; R35
  R43 | C
  R: 35-43
  S: (1/2-)7/8-26-36/37/39-45 | | |
| 607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | | 433-910-5 | 145153-52-2 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | | 434-360-9 | 91125-43-8 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 607-652-00-0 | ethyl N
  2-dodecanoyl-L-argininate hydrochloride | | 434-630-6 | 60372-77-2 | Xi; R41
  N; R50 | Xi; N
  R: 41-50
  S: (2-)26-39-61 | | |
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | | 434-840-8 | 225786-91-4 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 607-654-00-1 | (S)-3-hydroxy-γ-butyrolactone | | 434-990-4 | 7331-52-4 | R43 | Xi
  R: 43
  S: (2-)23-24-37 | | |
| 607-655-00-7 | ethyl 6,8-dichlorooctanoate | | 435-080-1 | 1070-64-0 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | | 435-350-7 | 141250-43-3 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | | 436-920-8 | 172399-10-9 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | | 440-770-9 | 371921-63-0 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 607-659-00-9 | pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | | 442-030-0 | 321912-47-4 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | | 442-230-8 | 321679-52-1 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-661-00-X | 1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate | | 442-850-9 | 114772-40-6 | R43
  R53 | Xi
  R: 43-53
  S: (2-)22-24-37-61 | | |
| 607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | | 442-860-3 | 87333-22-0 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-60-61 | | |
| 607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | | 442-980-6 | 127474-91-3 | R53 | R: 53
  S: 61 | | |
| 607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | | 443-120-2 | 393509-79-0 | Xi; R41
  N; R51-53 | Xi; N
  R: 41-51/53
  S: (2-)26-39-61 | | |
| 607-665-00-1 | trans-methyl-2-ethyl-but-2-enoate | | 443-150-6 | 101226-85-1 | R10 | R: 10
  S: 23 | | |
| 607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | | 443-560-5 | 88784-33-2 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | | 444-950-8 | 99464-83-2 | Muta.Cat.3; R68
  R43 | Xn
  R: 43-68
  S: (2-)23-36/37 | | |
| 607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxane | | 445-770-2 | 42031-28-7 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | | 445-990-9 | 376588-17-9 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
  (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | | 448-700-9 | 500791-70-8 | Xn; R48/22
  Xi; R41
  R43
  N; R50-53 | Xn; N
  R: 41-43-48/22-50/53
  S: (2-)22-26-36/37/39-60-61 | C ≥ 10 %: Xn, N; R41-43-48/22-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | | 417-310-0 | 72903-27-6 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 607-672-00-X | mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
  1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
  x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | | 419-000-0 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | | 419-570-0 | — | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)61 | | |
| 607-674-00-0 | branched C10-alkyl benzoates | | 421-090-1 | 131298-44-7 | Xn; R20 | Xn
  R: 20
  S: (2-)23 | | |
| 607-675-00-6 | mixture of: cis-9-octadecenedioic acid;

  cis-9-cis-12-octadecadienedioic acid;
  hexadecanedioic acid;
  octadecanedioic acid | | 422-260-8 | — | Xi; R41
  N; R50-53 | Xi; N
  R: 41-50/53
  S: (2-)26-39-60-61 | | |
| 607-676-00-1 | mixture of: 2-methylnonanedioic acid;
  2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
  2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
  8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | | 423-670-1 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate | | 424-660-8 | — | Xn; R48/22
  Xi; R41
  R43 | Xn
  R: 41-43-48/22
  S: (2-)22-26-36/37/39 | | |
| 607-678-00-2 | mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
  ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | | 427-090-8 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)23-25-36/37-61 | | |
| 607-679-00-8 | mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
  3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
  3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) | | 431-440-5 | — | Xi; R41
  N; R51-53 | Xi; N
  R: 41-51/53
  S: (2-)22-26-39-61 | | |
| 607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | | 432-810-9 | — | R53 | R: 53
  S: 61 | | |
| 607-681-00-9 | mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
  9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
  dihexadecyl 9-nonyl-10-octylnonadecandioate;
  1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
  dioctadecyl 9-nonyl-10-octylnonadecandioate | | 432-910-2 | — | R53 | R: 53
  S: 61 | | |
| 607-682-00-4 | complex mixture of Chinese gum rosin post reacted with acrylic acid | | 434-230-1 | 144413-22-9 | R53 | R: 53
  S: 61 | | |
| 607-683-00-X | mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
  methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | | 435-450-0 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-684-00-5 | alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | | 435-660-2 | 243662-67-1 | Xi; R38
  R43 | Xi
  R: 38-43
  S: (2-)24-37 | | |
| 607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | | 441-050-7 | — | Xi; R38-41 | Xi
  R: 38-41
  S: (2-)26-37/39 | | |
| 607-686-00-6 | 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | | 441-550-5 | — | E; R2
  F; R11
  Carc. Cat. 3; R40 | E; Xn
  R: 2-11-40
  S: (2-)7-22-36/37 | | |
| 607-687-00-1 | mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
  2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
  2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
  2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
  2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
  2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
  2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) | | 442-800-6 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)37-61 | | |
| 607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | | 444-320-2 | — | Xn; R22 | Xn
  R: 22
  S: (2-) | | |
| 607-689-00-2 | mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);
  methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers) | | 444-920-4 | — | R52-53 | R: 52/53
  S: 61 | | |
| 607-690-00-8 | dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate | | 432-860-1 | 255387-46-3 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-691-00-3 | magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | | 448-690-6 | — | R53 | R: 53
  S: 61 | | |
| 607-692-00-9 | zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | | 446-470-4 | — | R53 | R: 53
  S: 61 | | |
| 607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | | 443-860-6 | 302776-68-7 | R53 | R: 53
  S: 61 | | |
| 607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | | 443-870-0 | 163520-33-0 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)22-36/37-60-61 | | |
| 608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | | 421-810-4 | 194602-27-2 | Xn; R22
  Xi; R41
  R43
  N; R51-53 | Xn; N
  R: 22-41-43-51/53
  S: (2-)24-26-37/39-61 | | |
| 608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | | 421-240-6 | 120068-79-3 | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | | 421-300-1 | 138564-59-7 | N; R50-53 | N
  R: 50/53
  S: 22-60-61 | | |
| 608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | | 422-810-7 | 82380-18-5 | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | | 441-070-6 | 61826-76-4 | T; R25
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 25-41-43-50/53
  S: (1/2-)9-26-36/37/39-45-60-61 | | |
| 608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | | 433-720-2 | — | R52-53 | R: 52/53
  S: 61 | | |
| 609-069-00-7 | musk ketone;
  3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
  4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone | | 201-328-9 | 81-14-1 | Carc. Cat. 3; R40
  N; R50-53 | Xn; N
  R: 40-50/53
  S: (2-)36/37-46-60-61 | | |
| 611-154-00-9 | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate | | 403-670-6 | 92408-46-3 | R52-53 | R: 52/53
  S: 61 | | |
| 611-155-00-4 | 4,4′-oxybis(benzenesulfonylazide) | | 431-850-4 | 7456-68-0 | E; R3
  F; R11
  Xn; R48/22
  N; R50-53 | E; Xn; N
  R: 3-11-48/22-50/53
  S: (2-)14-22-33-35-36-60-61 | | |
| 611-156-00-X | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate | | 432-270-4 | 221354-37-6 | Repr. Cat. 3; R62
  Xn; R48/22
  N; R51-53 | Xn; N
  R: 48/22-62-51/53
  S: (2-)36/37-61 | | |
| 611-157-00-5 | benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
  potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate | | 432-590-4 | 243869-48-9 | Xi; R36
  R52-53 | Xi
  R: 36-52/53
  S: (2-)26-61 | | |
| 611-158-00-0 | reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | | 421-520-8 | — | F; R11
  R53 | F
  R: 11-53
  S: (2-)3-12-16-33-61 | | |
| 611-159-00-6 | disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate | | 421-880-6 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 611-160-00-1 | mixture of: 1,1,1-tris(phenyl-4′-(3′′-diazo-3′′,4′′-dihydro-4′′-oxo-naphthalene-1′′-sulfonato)ethane;
  1,1,1-tris(phenyl-4′-(6′′-diazo-5′′,6′′-dihydro-5′′-oxo-naphthalene-1′′-sulfonato)ethane;
  reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
  reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | | 422-760-6 | — | F; R11
  R53 | F
  R: 11-53
  S: (2-)3-12-33-61 | | |
| 611-161-00-7 | trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) | | 423-100-1 | — | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | | 429-600-4 | — | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | | 429-610-9 | — | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 611-164-00-3 | mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;
  2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);
  2,2′-dimethyl-2,2′-azoheptanenitrile;
  2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);
  2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile) | | 429-710-2 | — | R10
  R32
  R44
  Xn; R22
  N; R51-53 | Xn; N
  R: 10-22-32-44-51/53
  S: (2-)12-15-16-47-51-61 | | |
| 611-165-00-9 | mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
  tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | | 431-830-5 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-166-00-4 | mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
  tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 432-100-9 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 611-167-00-X | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II) | | 435-240-9 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-168-00-5 | mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
  3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | | 435-440-6 | — | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 611-169-00-0 | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | | 435-800-2 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-170-00-6 | mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
  disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II) | | 435-880-9 | — | R52-53 | R: 52/53
  S: 22-61 | | |
| 611-171-00-1 | mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
  trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | | 436-890-6 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 611-172-00-7 | mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
  diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate | | 438-310-7 | — | E; R2
  Repr. Cat. 3; R62
  Xn; R22-48/22
  R52-53 | E; Xn
  R: 2-22-48/22-62-52/53
  S: (2-)22-35-36/37-61 | | |
| 611-173-00-2 | mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
  3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | | 440-510-4 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-26-36/37/39 | | |
| 611-174-00-8 | mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
  3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | | 442-290-5 | 457624-86-1 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 611-175-00-3 | mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | | 444-050-5 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | | 444-250-2 | — | E; R2
  F; R11
  N; R51-53 | E; N
  R: 2-11-51/53
  S: (2-)22-61 | | |
| 611-177-00-4 | mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
  tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
  trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III) | | 444-290-0 | 508202-43-5 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)22-24-26-37/39-61 | | |
| 611-178-00-X | mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
  tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
  trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 445-280-9 | — | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)24-26-37/39-61 | | |
| 611-179-00-5 | mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
  2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | | 450-010-8 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-24-26-37/39 | | |
| 611-180-00-0 | iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | | 417-850-7 | — | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 612-238-00-8 | (3-chloro-2-hydroxypropyl) trimethylammonium chloride ... % | B | 222-048-3 | 3327-22-8 | Carc. Cat. 3, R40
  R52-53 | Xn
  R: 40-52/53
  S: 36/37-61 | | |
| 612-239-00-3 | biphenyl-3,3′,4,4′-tetrayltetraamine;
  diaminobenzidine | | 202-110-6 | 91-95-2 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68 | T
  R: 45-68
  S: 53-45 | | |
| 612-240-00-9 | pyrimethanil (ISO);

  N-(4,6-dimethylpyrimidin-2-yl)aniline | | — | 53112-28-0 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-241-00-4 | piperazine hydrochloride; [1]
  piperazine dihydrochloride; [2]
  piperazine phosphate [3] | | 228-042-7 [1]
  205-551-2 [2]
  217-775-8 [3] | 6094-40-2 [1]
  142-64-3 [2]
  1951-97-9 [3] | Repr. Cat. 3; R62-63
  Xi; R36/38
  R42/43
  R52-53 | Xn
  R: 36/38-42/43-62-63-52/53
  S: (1/2-)22-36/37-45-63-61 | | |
| 612-242-00-X | cyprodinil (ISO);
  4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | | — | 121552-61-2 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-46-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-243-00-5 | (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | | 420-560-3 | 79617-97-3 | Xi; R41
  N; R50-53 | Xi; N
  R: 41-50/53
  S: (2-)26-39-60-61 | C ≥ 10 %: Xi, N; R41-50/53
  5 % ≤ C < 10 %: Xi, N; R36-50/53
  2,5 % ≤ C < 5 %: N; R50/53
  0,25 % ≤ C < 2, 5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | | 421-310-6 | 87691-88-1 | Repr. Cat. 3; R62
  Xn; R22
  Xi; R36
  R43
  N; R50-53 | Xn; N
  R: 22-36-43-62-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 612-245-00-6 | 2-ethylphenylhydrazine hydrochloride | | 421-460-2 | 19398-06-2 | Carc. Cat. 3; R40
  T; R48/25
  Xn; R22
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 22-40-41-43-48/25-50/53
  S: (1/2-)22-26-36/37/39-45-60-61 | C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53
  10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53
  5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53
  2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-246-00-1 | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | E | 429-740-6 | 40722-80-3 | Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Xn; R48/22
  R43
  R52-53 | T
  R: 45-46-43-48/22-52/53
  S: 53-45-61 | | |
| 612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide | | 423-530-8 | 152828-23-4 | T; R48/25
  Xn; R22
  R52-53 | T
  R: 22-48/25-52/53
  S: (1/2-)22-36-45-61 | | |
| 612-248-00-2 | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) | | 439-540-0 | — | Xi; R38
  R43
  R53 | Xi
  R: 38-43-53
  S: (2-)24-37-61 | | |
| 612-249-00-8 | 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | | 425-030-5 | 159939-85-2 | Repr. Cat. 3; R62
  Xn; R22
  C; R34
  R43
  N; R51-53 | C; N
  R: 22-34-43-62-51/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 612-250-00-3 | chloro-N,N-dimethylformiminium chloride | E | 425-970-6 | 3724-43-4 | R14
  Repr. Cat. 2; R61
  Xn; R22
  C; R35 | T; C
  R: 61-14-22-35
  S: 53-45 | | |
| 612-251-00-9 | cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | | 426-020-3 | 51229-78-8 | F; R11
  Repr. Cat. 3; R63
  Xn; R22
  Xi; R38
  R43
  N; R51-53 | F; Xn; N
  R: 11-22-38-43-63-51/53
  S: (2-)7-22-33-36/37-61 | | |
| 612-252-00-4 | imidacloprid (ISO);
  1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine | | 428-040-8 | 138261-41-3 | Xn; R22
  N; R50-53 | Xn; N
  R: 22-50/53
  S: (2-)22-57-60-61 | | |
| 612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
  [containing < 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | R52-53 | R: R52/53
  S: 61 | | |
| 612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
  [containing ≥ 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | Repr. Cat. 2; R61
  R52-53 | T
  R: 61-52/53
  S: 53-45-61 | | |
| 612-254-00-5 | reaction products of diisopropanolamine with formaldehyde (1:4) | | 432-440-8 | 220444-73-5 | Carc. Cat. 3; R40
  Xn; R22
  C; R34
  R43
  N; R51-53 | C; N
  R: 22-34-40-43-51/53
  S: (1/2-)13-25-26-36/37/39-45-61 | | |
| 612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamine | | 431-950-8 | 179474-79-4 | Xn; R21/22
  C; R34
  R52-53 | C
  R: 21/22-34-52/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 612-256-00-6 | benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | | 427-470-3 | 137864-22-3 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)36/37 | | |
| 612-257-00-1 | tripropylammonium dihydrogenphosphate | | 433-700-3 | 35687-90-2 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | | 437-720-3 | 227085-51-0 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 612-261-00-3 | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | | 441-190-9 | 121451-05-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  2,5 % ≤ C < 25 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | | 444-360-0 | 191617-13-7 | R52-53 | R: 52/53
  S: 61 | | |
| 612-266-00-0 | 3-chloro-4-(3-fluorobenzyloxy)aniline | | 445-590-4 | 202197-26-0 | Muta. Cat. 3; R68
  Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-48/22-68-50/53
  S: (2-)22-36/37-60-61 | | |
| 612-267-00-6 | bis(hydrogenated tallow C16-18-alkyl)hydroxylamine | | 418-370-0 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)36/37-61 | | |
| 612-269-00-7 | mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
  1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
  mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

  N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | | 420-720-2 | — | R53 | R: 53
  S: 22-61 | | |
| 612-270-00-2 | (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | | 433-010-2 | — | Xn; R22
  R43
  R52-53 | Xn
  R: 22-43-52/53
  S: (2-)22-36/37-61 | | |
| 612-271-00-8 | mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
  ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | | 434-970-5 | 160987-57-5 | R53 | R: 53
  S: 61 | | |
| 612-272-00-3 | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate | | 435-210-5 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-273-00-9 | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | | 435-650-8 | — | Xn; R22
  C; R35
  N; R50-53 | C; N
  R: 22-35-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 612-274-00-4 | (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate | | 445-750-3 | — | Xn; R22
  Xi; R41
  R43
  R52-53 | Xn
  R: 22-41-43-52/53
  S: (2-)22-24-26-37/39-61 | | |
| 612-275-00-X | fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | | 447-880-6 | 206565-89-1 | Xi; R38-41
  R43
  N; R50-53 | Xi; N
  R: 38-41-43-50/53
  S: (2-)23-26-36/37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-43-50/53
  10 % ≤ C < 20 %: Xi, N; R41-43-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-276-00-5 | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | | 451-430-4 | 500717-36-2 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)22-24-26-36/37/39-61 | | |
| 612-277-00-0 | mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
  4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium | | 451-440-9 | 586372-44-3 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 612-278-00-6 | ethidium bromide;
  3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | | 214-984-6 | 1239-45-8 | Muta. Cat. 3; R68
  T+; R26
  Xn; R22 | T+
  R: 22-26-68
  S: (1/2-)28-36/37-45-63 | | |
| 612-279-00-1 | (R,S)-2-amino-3,3-dimethylbutane amide | | 447-860-7 | 144177-62-8 | Repr. Cat. 3; R62
  Xn; R48/22
  Xi; R36/38
  R43 | Xn
  R: 36/38-43-48/22-62
  S: (2-)22-26-36/37 | | |
| 612-280-00-7 | 3-amino-9-ethyl carbazole;
  9-ethylcarbazol-3-ylamine | H | 205-057-7 | 132-32-1 | Carc. Cat. 2; R45 | T
  R: 45
  S: 53-45 | | |
| 613-116-01-4 | tolylfluanid (ISO);
  dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
  [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | Xi; R36/37/38
  R43
  N; R50 | Xi; N
  R: 36/37/38-43-50
  S: (2-)25-36/37-46-61 | C ≥ 20 %: Xi, N; R36/37/38-43-50
  2,5 % ≤ C < 20 %: Xi, N; R43-50
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
  dimethyl propyleneurea | | 230-625-6 | 7226-23-5 | Repr. Cat. 3; R62
  Xn; R22
  Xi; R41 | Xn
  R: 22-41-62
  S: 26-36/37/39 | | |
| 613-281-00-5 | quinoline | E | 202-051-6 | 91-22-5 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Xn; R21/22
  Xi; R36/38
  N; R51-53 | T; N
  R: 45-21/22-36/38-68-51/53
  S: 53-45-61 | | |
| 613-282-00-0 | triticonazole (ISO);
  (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | | — | 131983-72-7 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 613-283-00-6 | ketoconazole;
  1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | E | 265-667-4 | 65277-42-1 | Repr. Cat. 2; R60
  T; R25
  Xn; R48/22
  N; R50-53 | T; N
  R: 60-25-48/22-50/53
  S: 53-45-60-61 | | |
| 613-284-00-1 | metconazole (ISO);
  (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | | — | 125116-23-6 | Repr. Cat. 3; R63
  Xn; R22
  N; R51-53 | Xn; N
  R: 22-63-51/53
  S: (2-)36/37-46-61 | | |
| 613-285-00-7 | 1-hydroxybenzotriazole, anhydrous; [1]
  1-hydroxybenzotriazole, monohydrated [2] | | 219-989-7 [1]
  219-989-7 [2] | 2592-95-2 [1]
  123333-53-9 [2] | E; R2 | E
  R: 2
  S: 16-35 | | |
| 613-286-00-2 | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
  [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 613-286-01-X | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
  [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | Repr. Cat. 2; R61
  R43 | T
  R: 61-43
  S: 53-45 | | |
| 613-287-00-8 | 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | | 419-540-7 | 160194-26-3 | Xn; R22
  R43
  N; R51-53 | Xn; N
  R: 22-43-51/53
  S: (2-)24-37-61 | | |
| 613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | | 420-930-4 | 135756-61-5 | Xn; R22
  Xi; R41
  R52-53 | Xn
  R: 22-41-52/53
  S: (2-)22-26-37/39-61 | | |
| 613-289-00-9 | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | | 432-020-4 | 142623-48-1 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | | 432-470-1 | 189012-93-9 | Xi; R41
  R43
  N; R50-53 | Xi; N
  R: 41-43-50/53
  S: (2-)24-26-37/39-60-61 | | |
| 613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | | 434-820-9 | 106461-41-0 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)22-36-60-61 | | |
| 613-292-00-5 | N,N′,N′′-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | | 435-010-8 | 26157-73-3 | Muta. Cat. 3; R68
  R52-53 | Xn
  R: 68-52/53
  S: (2-)36/37-61 | | |
| 613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | | 448-050-6 | 444065-11-6 | R53 | R: 53
  S: 61 | | |
| 613-294-00-6 | 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | | 448-260-8 | 379268-96-9 | R53 | R: 53
  S: 61 | | |
| 613-295-00-1 | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride | | 448-720-8 | 363138-44-7 | Xn; R22
  Xi; R41
  R52-53 | Xn
  R: 22-41-52/53
  S: (2-)22-26-39-61 | | |
| 613-296-00-7 | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | | 418-270-7 | — | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-47-61 | | |
| 613-297-00-2 | 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | | 420-820-6 | — | R10
  Xn; R22
  N; R51-53 | Xn; N
  R: 10-22-51/53
  S: (2-)16-61 | | |
| 613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | | 421-560-6 | — | Xn; R48/22
  Xi; R41
  N; R51-53 | Xn; N
  R: 41-48/22-51/53
  S: (2-)22-26-36/39-61 | | |
| 613-299-00-3 | main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
  main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
  main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
  main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt | | 422-610-1 | — | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | | 434-120-3 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate | | 443-910-7 | — | R53 | R: 53
  S: 61 | | |
| 613-302-00-8 | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | | 432-980-4 | 243858-60-8 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine | | 429-800-1 | 95737-68-1 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | | 421-170-6 | 138937-28-7 | Xn; R22
  Xi; R41 | Xn
  R: 22-41
  S: (2-)22-26-39 | | |
| 613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | | 448-630-9 | 3147-77-1 | R53 | R: 53
  S: 61 | | |
| 613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | | 433-520-5 | 82911-69-1 | Xn; R22
  R43
  N; R51-53 | Xn; N
  R: 22-43-51/53
  S: (2-)24-37-61 | | |
| 613-307-00-5 | clothianidin (ISO);
  3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine | | — | 210880-92-5 | Xn; R22
  N; R50-53 | Xn; N
  R: 22-50/53
  S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R22-50/53
  2,5 % ≤ C < 25 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 613-308-00-0 | 2-amino-5-methylthiazole | | 423-800-5 | 7305-71-7 | Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-48/22-50/53
  S: (2-)22-36-60-61 | | |
| 613-309-00-6 | 1-methyl-3-phenyl-1-piperazine | | 431-180-2 | 5271-27-2 | Xn; R21/22
  Xi; R38-41
  R52-53 | Xn
  R: 21/22-38-41-52/53
  S: (2-)26-36/37/39-61 | | |
| 613-310-00-1 | (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | | 432-360-3 | 105813-13-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)22-24-37-60-61 | | |
| 613-311-00-7 | methyl-5-nitrophenyl-guanidine | | 435-500-1 | 152460-07-6 | Xn; R22
  Xi; R36
  R43
  R52-53 | Xn
  R: 22-36-43-52/53
  S: (2-)22-24-26-37-61 | | |
| 613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | | 420-200-5 | — | Xn; R22
  Xi; R41
  R43
  R52-53 | Xn
  R: 22-41-43-52/53
  S: (2-)22-26-36/37/39-61 | | |
| 613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione | | 442-780-9 | 173838-67-0 | R52-53 | R: 52/53
  S: 61 | | |
| 613-314-00-3 | 4-decyloxazolidin-2-one;
  4-decyl-1,3-oxazolidin-2-one | | 443-770-7 | 7693-82-5 | N; R50-53 | N
  R: 50/53
  S: 22-24-60-61 | | |
| 613-315-00-9 | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | | 430-390-1 | — | Xn; R20
  R52-53 | Xn
  R: 20-52/53
  S: (2-)25-61 | | |
| 613-316-00-4 | trimethylopropane tri(3-aziridinylpropanoate);
  (TAZ) | H | 257-765-0 | 52234-82-9 | Muta. Cat. 3; R68
  Xi; R41
  R43 | Xn
  R: 41-43-68
  S: 26-36/37/39-42 | | |
| 615-044-00-1 | 4-chlorophenylisocyanate | | 203-176-9 | 104-12-1 | T+; R26
  Xn; R22
  Xi; R37/38-41
  R42
  N; R50-53 | T+; N
  R: 22-26-37/38-41-42-50/53
  S: (1/2-)26-28-36/37/39-45-63-60-61 | | |
| 615-045-00-7 | 4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | | 420-530-1 | — | R42/43
  R53 | Xn
  R: 42/43-53
  S: (2-)23-24-37-45-61 | | |
| 616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide | | 423-960-6 | 139756-01-7 | Xn; R22-48/22
  R52-53 | Xn
  R: 22-48/22-52/53
  S: (2-)22-36/37-61 | | |
| 616-164-00-7 | dimoxystrobin (ISO);
  (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide | | — | 149961-52-4 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  Xn; R20
  N; R50-53 | Xn; N
  R: 20-40-63-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-40-63-50/53
  5 % ≤ C < 25 %: Xn, N; R40-63-50/53
  2,5 % ≤ C < 5 %: Xn, N; R40-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52-53 | |
| 616-165-00-2 | beflubutamid (ISO);
  (RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide | | — | 113614-08-7 | N; R50-53 | N
  R: 50/53
  S: 60-61 | C ≥ 0,25 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | |
| 616-166-00-8 | cyazofamid (ISO);
  4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide | | — | 120116-88-3 | N; R50-53 | N
  R: 50/53
  S: 60-61 | C ≥ 2,5 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51-53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 616-167-00-3 | N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide | | 418-290-6 | 168612-06-4 | Xi; R36
  R43 | Xi
  R: 36-43
  S: (2-)24-26-37 | | |
| 616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | | 418-440-0 | 136997-71-2 | R43 | Xi
  R: 43
  S: (2-)22-24-37 | | |
| 616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one | | 420-220-4 | 92771-56-7 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-170-00-X | (2R)-2-amino-2-phenylacetamide | | 420-370-0 | 6485-67-2 | Xi; R36
  R43 | Xi
  R: 36-43
  S: (2-)22-26-36/37 | | |
| 616-171-00-5 | 2-(para-chlorophenyl)glycineamide | | 420-830-0 | 102333-75-5 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 616-172-00-0 | N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
  (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl | | 423-840-3 | 14691-89-5 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | | 424-560-4 | 151257-01-1 | Xn; R22
  Xi; R36 | Xn
  R: 22-36
  S: (2-)22-26 | | |
| 616-175-00-7 | 2-(2-hexyldecyloxy)benzamide | | 431-230-3 | 202483-62-3 | R53 | R: 53
  S: 61 | | |
| 616-176-00-2 | 3-N,N-bis(methoxyethyl)aminoacetanilide | | 432-530-7 | 24294-01-7 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)22-24-61 | | |
| 616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

  N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide | | 432-970-1 | 217324-98-6 | R53 | R: 53
  S: 61 | | |
| 616-178-00-3 | N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide | | 434-500-9 | 52583-35-4 | R53 | R: 53
  S: 22-61 | | |
| 616-179-00-9 | 2-chloro-N-(4-methylphenyl)acetamide | | 435-170-9 | 16634-82-5 | Xi; R41
  R43
  N; R50-53 | Xi; N
  R: 41-43-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 616-180-00-4 | N,N-(dimethylamino)thioacetamide hydrochloride | | 435-470-1 | 27366-72-9 | Repr. Cat. 2; R61
  N; R50-53 | T; N
  R: 61-50/53
  S: 53-45-60-61 | | |
| 616-181-00-X | 4′-methyldodecane-1-sulfonanilide | | 435-490-9 | 17417-32-2 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 616-182-00-5 | N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide | | 435-860-1 | 214417-91-1 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 616-183-00-0 | N-dodecyl-4-methoxybenzamide | | 442-340-6 | 1854-15-5 | R53 | R: 53
  S: 61 | | |
| 616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide | | 442-560-2 | 105043-55-8 | R53 | R: 53
  S: 61 | | |
| 616-186-00-7 | N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) | | 443-010-4 | 53641-10-4 | R52-53 | R: 52/53
  S: 61 | | |
| 616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide | | 443-980-9 | 221215-20-9 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide | | 444-780-4 | 452962-97-9 | R53 | R: 53
  S: 61 | | |
| 616-190-00-9 | N-decyl-4-nitrobenzamide | | 445-880-0 | 64026-19-3 | R53 | R: 53
  S: 61 | | |
| 616-191-00-4 | 2-ethyl-N-methyl-N-(3-methylphenyl)butanamide | | 446-190-2 | 406488-30-0 | Xn; R22
  Xi; R36/38
  R43
  N; R51-53 | Xn; N
  R: 22-36/38-43-51/53
  S: (2-)24-26-37-61 | | |
| 616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide | | 448-060-0 | 727678-39-9 | R53 | R: 53
  S: 61 | | |
| 616-193-00-5 | N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide | | 449-940-7 | 368450-39-9 | R53 | R: 53
  S: 61 | | |
| 616-194-00-0 | 2,2-diethoxy-N,N-dimethylacetamide | | 449-950-1 | 34640-92-1 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 616-196-00-1 | disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide | | 419-990-4 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 616-197-00-7 | mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

  N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide | | 422-500-1 | — | Xn; R48/22 | Xn
  R: 48/22
  S: (2-)22-36 | | |
| 616-198-00-2 | 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene | | 423-300-7 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-200-00-1 | mixture of: N,N′-ethane-1,2-diylbis(hexanamide);
  12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

  N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide) | | 432-430-3 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-201-00-7 | 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine | | 432-840-2 | 220926-97-6 | Xn; R20
  R53 | Xn
  R: 20-53
  S: (2-)22-61 | | |
| 616-202-00-2 | mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
  2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
  2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide | | 434-330-5 | — | Carc. Cat. 3; R40
  R43
  R53 | Xn
  R: 40-43-53
  S: (2-)36/37-61 | | |
| 616-203-00-8 | mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

  N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide | | 442-280-0 | — | R53 | R: 53
  S: 61 | | |
| 616-204-00-3 | N,N′′-(methylenedi-4,1-phenylene)bis[N′-octylurea] | | 451-060-3 | 122886-55-9 | R53 | R: 53
  S: 61 | | |
| 617-022-00-7 | mixture of: 1,2-dimethylpropylidene dihydroperoxide;
  dimethyl 1,2-benzenedicarboxylate | | 442-480-8 | — | O; R7
  Xn; R22
  C; R34
  R43
  N; R51-53 | O; C; N
  R: 7-22-34-43-51/53
  S: (1/2-)3/7-14-26-36/37/39-45-50-61 | | |
| 647-017-00-5 | laccase | | 420-150-4 | 80498-15-3 | R42 | Xn
  R: 42
  S: (2-)23-45 | | |

Index No

Chemical name

Notes related to substances

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes related to preparations

003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2

920-36-5

F; R15-17

R14

C; R35

R67

N; R50-53

F; C; N

R: 14/15-17-35-67-50/53

S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61

005-013-00-5

diethylmethoxyborane

425-380-9

7397-46-8

F; R17

Xn; R20/21/22-48/22

C; R34

R43

R53

F; C

R: 17-20/21/22-34-43-48/22-53

S: (1/2-)6-26-36/37/39-43-45-61

005-014-00-0

4-formylphenylboronic acid

438-670-5

87199-17-5

R43

Xi

R: 43

S: (2-)24-37

005-017-00-7

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-37-41-62

22 % ≤ C < 25 %: T; R61-37-41-62

20 % ≤ C < 22 %: T; R61-36/37-62

14 % ≤ C < 20 %: T; R61-36-62

9 % ≤ C < 14 %: T; R61-62

6,5 % ≤ C < 9 %: T; R61

005-017-01-4

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R23

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-23-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-23-37-41-62

22 % ≤ C < 25 %: T; R61-20-37-41-62

20 % ≤ C < 22 %: T; R61-20-36/37-62

14 % ≤ C < 20 %: T; R61-20-36-62

9 % ≤ C < 14 %: T; R61-20-62

6,5 % ≤ C < 9 %: T; R61-20

3 % ≤ C < 6,5 %: Xn; R20

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R37-41

T

R: 61-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-37-41-62

22 % ≤ C < 36 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R20

Xi; R37-41

T

R: 61-20-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-20-37-41-62

25 % ≤ C < 36 %: T; R61-20-36/37-62

22 % ≤ C < 25 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

006-097-00-6

1-phenyl-3-(p-toluenesulfonyl)urea

424-620-1

13909-63-2

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36-61

006-098-00-1

tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate

429-170-8

134575-17-0

Xn; R22-48/22

Xi; R41

R43

Xn

R: 22-41-43-48/22

S: (2-)22-26-36/37/39

006-099-00-7

N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate

432-520-2

232938-43-1

N; R51-53

N

R: 51/53

S: 22-61

006-101-00-6

mixture of: N,N′′-(methylenedi-4,1-phenylene)bis[N′-phenylurea];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;

N,N′′-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]

423-070-8

—

R53

R: 53

S: 61

006-102-00-1

O-hexyl-N-ethoxycarbonylthiocarbamate

E

432-750-3

—

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22-48/22

R43

N; R51-53

T; N

R: 45-46-22-43-48/22-51/53

S: 53-45-61

006-103-00-7

N,N′′-(methylenedi-4,1-phenylene)bis[N′-octyl]urea

445-760-8

—

Xi; R41

R42

N; R50-53

Xn; N

R: 41-42-50/53

S: (2-)22-26-39-45-60-61

C ≥10 %: Xn, N; R41-42-50/53

5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53

0,25 % ≤ C < 1 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 ≤ C < 0,025 %: R52/53

007-029-00-8

diethyldimethylammonium hydroxide

419-400-5

95500-19-9

Xn; R21/22

C; R35

C

R: 21/22-35

S: (1/2-)26-36/37/39-45

012-004-00-X

aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate

422-150-1

—

N; R50-53

N

R: 50/53

S: 60-61

014-036-00-X

(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

405-020-7

105024-66-6

Repr.Cat.2; R60

N; R50-53

T; N

R: 60-50/53

S: 53-45-60-61

C ≥ 0,5 %: T, N; R60-50/53

0,025 % ≤ C < 0,5 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

014-037-00-5

2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime

433-360-6

34036-80-1

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)36/37-61

014-038-00-0

S-(3-(triethoxysilyl)propyl)octanethioate

436-690-9

220727-26-4

R43

Xi

R: 43

S: (2-)24-37

014-039-00-6

(2,3-dimethylbut-2-yl)-trimethoxysilane

439-360-2

142877-45-0

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

014-041-00-7

N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane

445-890-5

201290-01-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)24-37

014-042-00-2

mixture of: O,O′,O′′,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)

423-010-0

—

Xi; R41

Xi

R: 41

S: (2-)26-39

014-043-00-8

reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)

432-200-2

—

F; R11

Xi; R37/38-41

R52-53

F; Xi

R: 11-37/38-41-52/53

S: (2-)6-26-36/39-61

014-044-00-3

3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane

433-050-0

—

N; R51-53

N

R: 51/53

S: 61

014-045-00-9

magnesium sodium fluoride silicate

442-650-1

—

Xn; R48/20

Xn

R: 48/20

S: (2-)22-36

015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

421-920-2

154862-43-8

R53

R: 53

S: 61

015-191-00-6

dodecyldiphenyl phosphate

431-760-5

27460-02-2

Xi; R38

R52-53

Xi

R: 38-52/53

S: (2-)37-61

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate

432-770-2

139189-30-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

015-193-00-7

triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)

442-960-7

332350-93-3

T; R25

Xi; R41

N; R50-53

T; N

R: 25-41-50/53

S: (1/2-)26-39-45-60-61

015-194-00-2

tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate

444-440-5

220689-12-3

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

015-195-00-8

mixture of: potassium o-toluenephosphonate;

potassium m-toluenephosphonate;

potassium p-toluenephosphonate

433-860-4

—

Xi; R36

R43

R52-53

Xi

R: 36-43-52/53

S: (2-)24-26-37-61

015-196-00-3

mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

435-960-3

—

Carc.Cat.2; R45

Muta.Cat.2; R46

R43

T

R: 45-46-43

S: 53-45

015-197-00-9

bis(2,4,4-trimethylpentyl)dithiophosphonic acid

420-160-9

107667-02-7

R10

T; R23

Xn; R22

C; R34

N; R51-53

T; N

R: 10-22-23-34-51/53

S: (1/2-)9-26-36/37/39-45-61

015-198-00-4

(4-phenylbutyl)phosphinic acid

420-450-5

86552-32-1

Carc.Cat.3; R40

Xi; R41

Xn

R: 40-41

S: (2-)23-26-36/37/39

016-094-00-1

sulfur

231-722-6

7704-34-9

Xi; R38

Xi

R: 38

S: (2-)46

016-097-00-8

1-amino-2-methyl-2-propanethiol hydrochloride

434-480-1

32047-53-3

Xn; R22

C; R34

R43

R52-53

C

R: 22-34-43-52/53

S: (1/2-)22-26-36/37/39-45-61

017-009-01-8

ammonium perchlorate;

[containing < 80 % of 0-30 μm particles]

T

232-235-1

7790-98-9

E; R2

O; R9

E

R: 2-9

S: (2-)14-16-36/37

022-004-00-1

potassium titanium oxide (K2Ti6O13)

432-240-0

12056-51-8

Carc.Cat.3; R40

Xn

R: 40

S: (2-)22-36/37

022-005-00-7

[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium

419-840-8

169104-71-6

F; R11

C; R34

R43

R53

F; C

R: 11-34-43-53

S: (1/2-)6-9-16-26-36/37/39-45-61

028-002-01-4

nickel powder;

[particle diameter < 1 mm]

231-111-4

7440-02-0

Carc. Cat. 3; R40

T; R48/23

R43

R52-53

T

R: 40-43-48/23-52/53

S: (2-)36/37/39-45-61

028-013-00-7

nickel matte

E, H

273-749-6

69012-50-6

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-014-00-2

slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate

E

295-859-3

92129-57-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53

20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53

2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-015-00-8

slimes and sludges, copper electrolyte refining, decopperised

E, H

305-433-1

94551-87-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-62-68-50/53

S: 53-45-60-61

028-016-00-3

nickel diperchlorate;

perchloric acid, nickel(II) salt

E, H

237-124-1

13637-71-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

C; R34

R42/43

N; R50-53

T; N

R: 49-61-34-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53

5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-017-00-9

nickel dipotassium bis(sulfate); [1]

diammonium nickel bis(sulfate) [2]

E, H

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

E, H

237-396-1

13770-89-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-019-00-X

nickel bis(tetrafluoroborate)

E, H

238-753-4

14708-14-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-021-00-0

nickel diformate; [1]

formic acid, nickel salt; [2]

formic acid, copper nickel salt [3]

E, H

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-022-00-6

nickel di(acetate); [1]

nickel acetate [2]

E, H

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-024-00-7

nickel dibenzoate

E, H

209-046-8

553-71-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-025-00-2

nickel bis(4-cyclohexylbutyrate)

E, H

223-463-2

3906-55-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-026-00-8

nickel(II) stearate;

nickel(II) octadecanoate

E, H

218-744-1

2223-95-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-027-00-3

nickel dilactate

E, H

—

16039-61-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-028-00-9

nickel(II) octanoate

E, H

225-656-7

4995-91-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat 2; R61

T; R48/23

C; R35

R42/43

N; R50-53

T; C; N

R: 49-61-35-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53

10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53

5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-029-00-4

nickel difluoride; [1]

nickel dibromide; [2]

nickel diiodide; [3]

nickel potassium fluoride [4]

E, H

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-030-00-X

nickel hexafluorosilicate

E, H

247-430-7

26043-11-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-031-00-5

nickel selenate

E, H

239-125-2

15060-62-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-032-00-0

nickel hydrogen phosphate; [1]

nickel bis(dihydrogen phosphate); [2]

trinickel bis(orthophosphate); [3]

dinickel diphosphate; [4]

nickel bis(phosphinate); [5]

nickel phosphinate; [6]

phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt [8]

E, H

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-033-00-6

diammonium nickel hexacyanoferrate

E, H

—

74195-78-1

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-034-00-1

nickel dicyanide

E, H

209-160-8

557-19-7

Carc. Cat. 1; R49

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-32-42/43-48/23-50/53

S: 53-45-60-61

028-035-00-7

nickel chromate

E, H

238-766-5

14721-18-7

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-036-00-2

nickel(II) silicate; [1]

dinickel orthosilicate; [2]

nickel silicate (3:4); [3]

silicic acid, nickel salt; [4]

trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

E, H

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-037-00-8

dinickel hexacyanoferrate

E, H

238-946-3

14874-78-3

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-038-00-3

trinickel bis(arsenate);

nickel(II) arsenate

E, H

236-771-7

13477-70-8

Carc. Cat. 1; R45

T; R48/23

R43

N; R50-53

T; N

R: 45-43-48/23-50/53

S: 53-45-60-61

028-039-00-9

nickel oxalate; [1]

oxalic acid, nickel salt [2]

E, H

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N: R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-040-00-4

nickel telluride

E, H

235-260-6

12142-88-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-041-00-X

trinickel tetrasulfide

E, H

—

12137-12-1

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-042-00-5

trinickel bis(arsenite)

E, H

—

74646-29-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-043-00-0

cobalt nickel gray periclase;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobalt nickel dioxide; [2]

cobalt nickel oxide [3]

E, H

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-044-00-6

nickel tin trioxide;

nickel stannate

E, H

234-824-9

12035-38-0

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-045-00-1

nickel triuranium decaoxide

E, H

239-876-6

15780-33-3

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-046-00-7

nickel dithiocyanate

E, H

237-205-1

13689-92-4

Carc. Cat. 1; R49

Muta. Cat. 3;R68

Repr. Cat. 2; R61

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-61-32-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-047-00-2

nickel dichromate

E, H

239-646-5

15586-38-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1% ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-048-00-8

nickel(II) selenite

E, H

233-263-7

10101-96-9

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-049-00-3

nickel selenide

E, H

215-216-2

1314-05-2

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-050-00-9

silicic acid, lead nickel salt

E, H

—

68130-19-8

Carc. Cat. 1: R49

Repr. Cat. 1: R61

Repr. Cat. 3; R62

T; R48/23

R43

N; R50-53

T; N

R: 49-61-43-48/23-62-50/53

S: 53-45-60-61

028-051-00-4

nickel diarsenide; [1]

nickel arsenide [2]

E, H

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-052-00-X

nickel barium titanium primrose priderite;

C.I. Pigment Yellow 157;

C.I. 77900

E, H

271-853-6

68610-24-2

Carc. Cat. 1: R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-053-00-5

nickel dichlorate; [1]

nickel dibromate; [2]

ethyl hydrogen sulfate, nickel(II) salt [3]

E, H

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T: R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-054-00-0

nickel(II) trifluoroacetate; [1]

nickel(II) propionate; [2]

nickel bis(benzenesulfonate); [3]

nickel(II) hydrogen citrate; [4]

citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6]

nickel bis(2-ethylhexanoate); [7]

2-ethylhexanoic acid, nickel salt; [8]

dimethylhexanoic acid nickel salt; [9]

nickel(II) isooctanoate; [10]

nickel isooctanoate; [11]

nickel bis(isononanoate); [12]

nickel(II) neononanoate; [13]

nickel(II) isodecanoate; [14]

nickel(II) neodecanoate; [15]

neodecanoic acid, nickel salt; [16]

nickel(II) neoundecanoate; [17]

bis(D-gluconato-O
  1,O
  2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]

nickel(II) palmitate; [20]

(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]

(isononanoato-O)(isooctanoato-O)nickel; [22]

(isooctanoato-O)(neodecanoato-O)nickel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]

(isodecanoato-O)(isooctanoato-O)nickel; [26]

(isodecanoato-O)(isononanoato-O)nickel; [27]

(isononanoato-O)(neodecanoato-O)nickel; [28]

fatty acids, C6-19-branched, nickel salts; [29]

fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]

2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

E, H

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-055-00-6

nickel(II) sulfite; [1]

nickel tellurium trioxide; [2]

nickel tellurium tetraoxide; [3]

molybdenum nickel hydroxide oxide phosphate [4]

E, H

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-056-00-1

nickel boride (NiB); [1]

dinickel boride; [2]

trinickel boride; [3]

nickel boride; [4]

dinickel silicide; [5]

nickel disilicide; [6]

dinickel phosphide; [7]

nickel boron phosphide [8]

E, H

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-057-00-7

dialuminium nickel tetraoxide; [1]

nickel titanium trioxide; [2]

nickel titanium oxide; [3]

nickel divanadium hexaoxide; [4]

cobalt dimolybdenum nickel octaoxide; [5]

nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7]

nickel tungsten tetraoxide; [8]

olivine, nickel green; [9]

lithium nickel dioxide; [10]

molybdenum nickel oxide; [11]

E, H

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-058-00-2

cobalt lithium nickel oxide

E

442-750-5

—

Carc. Cat. 1; R49

T+; R26

T; R48/23

R43

N; R50-53

T+; N

R: 49-26-43-48/23-50/53

S: 53-45-60-61

029-014-00-5

mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;

2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex

419-610-7

171866-24-3

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-51/53

S: (2-)22-36-61

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

R52-53

R: 52/53

S: 61

030-015-00-8

tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate

440-060-9

—

N; R51-53

N

R: 51/53

S: 61

042-005-00-0

mixture of: mono- and di-glycerols of canola oil;

canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

N,N-diorgano dithiocarbamate molybdenum complex

434-240-6

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

050-023-00-5

mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;

bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

422-920-5

—

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)23-36-60-61

C ≥ 10 %: Xn, N; R48/22-50/53

2,5 % ≤ C < 10 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

050-024-00-0

mixture of: tri-p-tolyltin hydroxide;

hexa-p-tolyl-distannoxane

432-230-6

—

T; R48/25

Xn; R22

Xi; R38-41

R43

N; R50-53

T; N

R: 22-38-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

064-001-00-8

gadolinium(III)sulfite trihydrate

456-900-2

51285-81-5

N; R51-53

N

R: 51/53

S: 61

078-011-00-5

hydroxydisulfito platinum(II) acid

423-310-1

61420-92-6

Xn; R22-48/20/21/22

C; R35

R42/43

R52-53

C

R: 22-35-42/43-48/20/21/22-52/53

S: (1/2-)23-24-26-28-36/37/39-45-61

078-012-00-0

platinum(IV) nitrate/nitric acid solution

432-400-1

—

C; R35

N; R50-53

C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61

082-012-00-6

barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped

431-780-4

199876-46-5

Xn; R22-48/22

N; R51-53

Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61

601-080-00-5

mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;

1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;

1-(sec-butylphenyl-1-phenylethane, mixed isomers

431-100-6

—

N; R50-53

N

R: 50/53

S: 60-61

601-081-00-0

cyclohexadeca-1,9-diene

431-730-1

4277-06-9

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)36/37-61

601-082-00-6

mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

434-420-4

—

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)23-26-37/39-57-60-61

601-083-00-1

5-endo-hexyl-bicyclo[2.2.1]hept-2-ene

435-000-3

22094-83-3

Xn; R65

Xi; R38

R53

Xn

R: 38-65-53

S: (2-)37-62-61

601-084-00-7

mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;

5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

435-180-3

—

Xn; R65

Xi; R38

N; R50-53

Xn; N

R: 38-65-50/53

S: (2-)37-62-60-61

602-105-00-2

sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate

422-100-7

102061-82-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

602-106-00-8

2-bromo-4,6-difluoroaniline

429-430-0

444-14-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-61

602-107-00-3

3,3,4,4-tetrafluoro-4-iodo-1-butene

439-500-2

33831-83-3

Xn; R22

Xi; R38

N; R51-53

Xn; N

R: 22-38-51/53

S: (2-)37-61

602-108-00-9

(2,3,5,6-tetrafluorophenyl)methanol

443-840-7

4084-38-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)26-36/37

603-211-00-1

2,3-epoxypropyltrimethylammonium chloride ... %;

glycidyl trimethylammonium chloride ... %

B E

221-221-0

3033-77-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R21/22-48/22

Xi; R41

R43

R52-53

T

R: 45-21/22-41-43-48/22-62-68-52/53

S: 53-45-61

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolide;

(HHCB)

214-946-9

1222-05-5

N; R50-53

N

R: 50/53

S: 60-61

603-213-00-2

2-methoxy-2-methylbutane;

tert-amyl methyl ether

213-611-4

994-05-8

F; R11

Xn; R22

R67

F; Xn

R: 11-22-67

S: (2-)9-16-23-33

603-214-00-8

1,1-diisopropoxycyclohexane

413-740-8

1132-95-2

C; R34

C

R: 34

S: (1/2-)23-26-36/37/39-45

603-215-00-3

1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)

418-330-2

162241-33-0

E; R2

Xn; R22-48/22

Xi; R41

R43

N; R50-53

E; Xn; N

R: 2-22-41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

603-216-00-9

cis-1-amino-2,3-dihydro-1H-inden-2-ol

422-660-2

7480-35-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

603-217-00-4

2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite

423-560-1

161717-32-4

R43

R53

Xi

R: 43-53

S: (2-)24-37/39-61

603-220-00-0

1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol

432-890-5

72955-94-3

R53

R: 53

S: 61

603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2

214353-17-0

Xn; R22

C; R34

N; R51-53

C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]

E

433-580-2

214353-17-0

Carc. Cat. 2; R45

Xn; R22

C; R34

N; R51-53

T; N

R: 45-22-34-51/53

S: 53-45-61

603-222-00-1

(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane

433-820-6

118058-74-5

Xi; R36

Xi

R: 36

S: (2-)26

603-223-00-7

2-cyclopentylidene cyclopentanol;

1,1′-bi(cyclopentyliden)-2-ol

434-270-1

6261-30-9

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

603-224-00-2

3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane

435-790-1

297730-93-9

R53

R: 53

S: 61

603-225-00-8

erythromycin A9-oxime (E);

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

437-070-0

13127-18-9

N; R51-53

N

R: 51/53

S: 61

603-226-00-3

4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol

444-500-0

1440-00-2

R52-53

R: 52/53

S: 61

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);

reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

445-060-2

203574-04-3

O; R7

N; R50-53

O; N

R: 7-50/53

S: (2-)3/7-14-36/37/39-60-61

603-228-00-4

(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluoro-2-(2-oxiranyl)chromane

419-620-1

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)36/37-61

603-229-00-X

sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate

420-800-7

—

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61

603-230-00-5

2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan

440-030-5

—

Xi; R38-41

R53

Xi

R: 38-41-53

S: (2-)26-37/39-61

603-231-00-0

(S)-1,1-diphenyl-1,2-propanediol

443-220-6

—

R52-53

R: 52/53

S: 22-61

603-232-00-6

3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane

444-420-6

—

R53

R: 53

S: 61

603-233-00-1

mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0

—

N; R51-53

N

R: 51/53

S: 61

603-234-00-7

(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene

444-480-3

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

604-074-00-0

tetrabromobisphenol-A;

2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol

201-236-9

79-94-7

N; R50-53

N

R: 50/53

S: 60-61

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

205-426-2

140-66-9

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61

C ≥ 20 %: Xi, N; R38-41-50/53

10 % ≤ C < 20 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

604-076-00-1

phenolphthalein

201-004-7

77-09-8

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T

R: 45-62-68

S: 53-45

C ≥ 5 %: T; R45-62-68

1 % ≤ C < 5 %: T; R45-68

604-077-00-7

2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol

419-750-9

98809-58-6

R53

R: 53

S: 61

604-079-00-8

4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol

428-970-4

13595-25-0

Repr.Cat.3; R62

R43

N; R51-53

Xn; N

R: 43-62-51/53

S: (2-)22-36/37-61

604-080-00-3

4-fluoro-3-trifluoromethylphenol

432-560-0

61721-07-1

Xn; R20

C; R35

R43

N; R51-53

C; N

R: 20-35-43-51/53

S: (1/2-)26-28-36/37/39-45-61

604-081-00-9

1,1-bis(4-hydroxyphenyl)-1-phenylethane

433-130-5

1571-75-1

N; R50-53

N

R: 50/53

S: 25-60-61

604-082-00-4

2-chloro-6-fluoro-phenol

E

433-890-8

2040-90-6

Muta.Cat.2; R46

Repr.Cat.3; R62

Xn; R22

C; R34

R43

N; R51-53

T; N

R: 46-22-34-43-62-51/53

S: 53-45-61

604-083-00-X

4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol

439-270-3

260408-02-4

R53

R: 53

S: 61

604-084-00-5

1-ethoxy-2,3-difluorobenzene

441-000-4

121219-07-6

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)23-61

604-087-00-1

mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

433-640-8

—

F; R17

R44

R53

F

R: 17-44-53

S: (2-)15-22-61

604-089-00-2

2-methyl-5-tert-butylthiophenol

444-970-7

—

R10

Repr.Cat.3; R63

Xn; R48/20/22-65

Xi; R36/38

R43

R67

N; R50-53

Xn; N

R: 10-36/38-43-48/20/22-63-65-67-50/53

S: (2-)26-36/37-62-60-61

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;

3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

421-800-1

120578-03-2

R53

R: 53

S: 22-61

605-038-00-7

3-methyl-5-phenylpentan-1-al

433-900-0

55066-49-4

Xn; R22

Xi; R38

R43

N; R51-53

Xn; N

R: 22-38-43-51/53

S: (2-)36/37-61

605-039-00-2

3,4-dihydroxy-5-nitrobenzaldehyde

441-810-8

116313-85-0

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

606-124-00-7

1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione

421-080-7

161462-35-7

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)36-60-61

606-125-00-2

1-benzylimidazolidine-2,4-dione

421-340-1

6777-05-5

Xn; R22

Xn

R: 22

S: (2-)22

606-126-00-8

1,4-bis(2,3-dihydroxypropylamino)anthraquinone

421-470-7

99788-75-7

N; R51-53

N

R: 51/53

S: 61

606-128-00-9

2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione

422-650-8

148935-94-8

R53

R: 53

S: 61

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;

(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

423-090-7

156732-13-7

R53

R: 53

S: 61

606-130-00-X

4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone

423-860-2

56309-94-5

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-131-00-5

cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione

E

427-230-8

5571-36-8

Repr. Cat. 2; R60

Xn; R48/22

N; R51-53

T; N

R: 60-48/22-51/53

S: 53-45-61

606-132-00-0

(6β)-6,19-epoxyandrost-4-ene-3,17-dione

433-490-3

6563-83-3

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-134-00-1

androsta-1,4,9(11)-triene-3,17-dione

433-560-3

15375-21-0

Repr. Cat.3; R62

Xn

R: 62

S: (2-)22-36/37

606-135-00-7

cyclohexadecanone

438-930-8

2550-52-9

R53

R: 53

S: 61

606-136-00-2

(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone

444-350-6

133413-70-4

Xi; R36

R53

Xi

R: 36-53

S: (2-)26-61

606-137-00-8

trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione

444-750-0

211387-26-7

R53

R: 53

S: 22-61

606-138-00-3

(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone

444-800-1

141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53

20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53

10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

606-139-00-9

(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one

444-830-5

124379-29-9

R53

R: 53

S: 61

606-140-00-4

2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one

444-860-9

474510-57-1

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

606-141-00-X

sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate

418-410-7

—

Xi; R36

Xi

R: 36

S: (2-)26

606-142-00-5

mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one

434-290-9

—

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)61

607-580-00-X

ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate

422-360-1

100491-29-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)22-24-37-61

607-618-00-5

menadione sodium bisulfite;

2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

204-987-0

130-37-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-619-00-0

menadione nicotinamide bisulfite;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

277-543-7

73581-79-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-620-00-6

trisodium nitrilotriacetate

225-768-6

5064-31-3

Carc. Cat. 3; R40

Xn; R22

Xi; R36

Xn

R: 22-36-40

S: (2-)26-36/37-46

C ≥ 25 %: Xn; R22-36-40

20 ≤ % C < 25 %: Xn; R36-40

5 ≤ % C < 20 %: Xn; R40

607-621-00-1

milbemectin (ISO);

[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

—

—

Xn; R20/22

N; R50-53

Xn; N

R: 20/22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R20/22-50/53

0,25 % ≤ C < 25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

607-622-00-7

2-ethylhexyl-2-ethylhexanoate

231-057-1

7425-14-1

Repr. Cat. 3; R63

Xn

R: 63

S: (2-)36/37

607-623-00-2

diisobutyl phthalate

201-553-2

84-69-5

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T

R: 61-62

S: 53-45

C ≥ 25 %: T; R61-62

5 % ≤ C < 25 %: Xn; R62

607-624-00-8

perfluorooctane sulfonic acid;

heptadecafluorooctane-1-sulfonic acid; [1]

potassium perfluorooctanesulfonate;

potassium heptadecafluorooctane-1-sulfonate; [2]

diethanolamine perfluorooctane sulfonate; [3]

ammonium perfluorooctane sulfonate;

ammonium heptadecafluorooctanesulfonate; [4]

lithium perfluorooctane sulfonate;

lithium heptadecafluorooctanesulfonate [5]

E

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T; R48/25

Xn; R20/22

R64

N; R51-53

T; N

R: 61-20/22-40-48/25-64-51/53

S: 53-45-61

607-625-00-3

clodinafop-propargyl (ISO)

—

105512-06-9

Xn; R22-48/22

R43

N; R50-53.

Xn; N

R: 22-43-48/22-50/53

S: (2-)24-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53

2,5 % ≤ C < 10 %: Xi, N; R43-51/53

0,25 % ≤ C < 2,5 %: Xi; R43-52/53

0,001 % ≤ C < 0,25 %: Xi; R43

607-626-00-9

ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate

401-290-5

103112-35-2

Carc.Cat.2; R45

N; R50-53

T; N

R: 45-50/53

S: 53-45-60-61

607-627-00-4

[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate

416-360-0

162221-28-5

R43

Xi

R: 43

S: (2-)22-24-37

607-628-00-X

4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine

419-240-6

171054-89-0

Xi; R41

Xi

R: 41

S: (2-)26-39

607-629-00-5

[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid

419-270-1

123599-82-6

Xi; R36

Xi

R: 36

S: (2-)26

607-630-00-0

acrylic acid, 3-(trimethoxysilyl)propyl ester

419-560-6

4369-14-6

Xn; R20

C; R34

R43

R52-53

C

R: 20-34-43-52/53

S: (1/2-)26-36/37/39-45-61

607-631-00-6

mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;

(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

442-300-8

—

R43

Xi

R: 43

S: (2-)24-37

607-632-00-1

N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide

420-210-1

111244-14-5

R53

R: 53

S: 61

607-633-00-7

trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate

440-480-2

341026-59-3

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

607-634-00-2

(S)-(-)-2-acetoxypropionylchloride;

(1S)-2-chloro-1-methyl-2-oxoethyl acetate

420-610-4

36394-75-9

Xn; R22

C; R34

R43

C

R: 22-34-43

S: (1/2-)23-26-36/37/39-45

607-635-00-8

trisodium N-(3-propionato)-L-aspartate

422-090-4

172737-80-3

Xi; R41

Xi

R: 41

S: (2-)26-39

607-636-00-3

1-bromo-2-methylpropyl propionate

422-900-6

158894-67-8

R10

Carc.Cat.3; R40

C; R34

R43

C

R: 10-34-40-43

S: (1/2-)7/9-8-23-26-36/37/39-45

607-637-00-9

disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate

423-730-5

250688-43-8

Xi; R41

Xi

R: 41

S: (2-)26-39

607-638-00-4

2-hydroxybenzoic acid 2-butyloctyl ester

431-090-3

190085-41-7

R53

R: 53

S: 61

607-639-00-X

2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate

431-770-1

216698-07-6

R53

R: 53

S: 61

607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;

2-formamido-3-thiophenecarboxylic acid

431-930-9

43028-69-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)22-24-37

607-642-00-6

3,6,9-trithiaundecamethylene-1,11-dimethacrylate

432-210-7

141631-22-3

N; R50-53

N

R: 50/53

S: 60-61

607-643-00-1

dimethyl (2S)-2-hydroxysuccinate

432-310-0

617-55-0

R10

Xi; R41

R43

Xi

R: 10-41-43

S: (2-)24-26-37/39-43

607-644-00-7

methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate

432-350-9

81752-87-6

Xi; R38

Xi

R: 38

S: (2-)37

607-645-00-2

tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate

432-550-6

243858-01-7

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-646-00-8

D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

432-960-5

124655-09-0

Xn; R22

Xn

R: 22

S: (2-)25

607-647-00-3

5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane

433-530-1

143446-73-5

Xn; R22

R43

N; R50

Xn; N

R: 22-43-50

S: (2-)24-37-57-61

607-649-00-4

[3-(chlorocarbonyl)-2-methylphenyl]acetate

433-690-0

167678-46-8

C; R35

R43

C

R: 35-43

S: (1/2-)7/8-26-36/37/39-45

607-650-00-X

2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate

433-910-5

145153-52-2

R43

Xi

R: 43

S: (2-)24-37

607-651-00-5

sodium 2-(nonanoyloxy)benzenesulfonate

434-360-9

91125-43-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-652-00-0

ethyl N
  2-dodecanoyl-L-argininate hydrochloride

434-630-6

60372-77-2

Xi; R41

N; R50

Xi; N

R: 41-50

S: (2-)26-39-61

607-653-00-6

tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate

434-840-8

225786-91-4

N; R51-53

N

R: 51/53

S: 61

607-654-00-1

(S)-3-hydroxy-γ-butyrolactone

434-990-4

7331-52-4

R43

Xi

R: 43

S: (2-)23-24-37

607-655-00-7

ethyl 6,8-dichlorooctanoate

435-080-1

1070-64-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-656-00-2

sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid

435-350-7

141250-43-3

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-657-00-8

pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate

436-920-8

172399-10-9

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-658-00-3

3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt

440-770-9

371921-63-0

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

607-659-00-9

pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid

442-030-0

321912-47-4

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-660-00-4

2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt

442-230-8

321679-52-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-661-00-X

1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate

442-850-9

114772-40-6

R43

R53

Xi

R: 43-53

S: (2-)22-24-37-61

607-662-00-5

methyl 2-(acetylamino)-3-chloropropionate

442-860-3

87333-22-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

607-663-00-0

bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate

442-980-6

127474-91-3

R53

R: 53

S: 61

607-664-00-6

methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate

443-120-2

393509-79-0

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)26-39-61

607-665-00-1

trans-methyl-2-ethyl-but-2-enoate

443-150-6

101226-85-1

R10

R: 10

S: 23

607-666-00-7

(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid

443-560-5

88784-33-2

Xi; R36

Xi

R: 36

S: (2-)26

607-667-00-2

chloro-1-ethylcyclohexyl carbonate

444-950-8

99464-83-2

Muta.Cat.3; R68

R43

Xn

R: 43-68

S: (2-)23-36/37

607-668-00-8

trans-2-isopropyl-5-carboxy-1,3-dioxane

445-770-2

42031-28-7

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-669-00-3

methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate

445-990-9

376588-17-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;

(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

448-700-9

500791-70-8

Xn; R48/22

Xi; R41

R43

N; R50-53

Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

C ≥ 10 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

607-671-00-4

diethyl 1,4-cyclohexanedicarboxylate

417-310-0

72903-27-6

N; R51-53

N

R: 51/53

S: 61

607-672-00-X

mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;

1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;

x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

419-000-0

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-673-00-5

1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate

419-570-0

—

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

607-674-00-0

branched C10-alkyl benzoates

421-090-1

131298-44-7

Xn; R20

Xn

R: 20

S: (2-)23

607-675-00-6

mixture of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid;

hexadecanedioic acid;

octadecanedioic acid

422-260-8

—

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

607-676-00-1

mixture of: 2-methylnonanedioic acid;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

423-670-1

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-677-00-7

2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate

424-660-8

—

Xn; R48/22

Xi; R41

R43

Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39

607-678-00-2

mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;

ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

427-090-8

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)23-25-36/37-61

607-679-00-8

mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);

3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);

3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)

431-440-5

—

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)22-26-39-61

607-680-00-3

tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate

432-810-9

—

R53

R: 53

S: 61

607-681-00-9

mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;

dihexadecyl 9-nonyl-10-octylnonadecandioate;

1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;

dioctadecyl 9-nonyl-10-octylnonadecandioate

432-910-2

—

R53

R: 53

S: 61

607-682-00-4

complex mixture of Chinese gum rosin post reacted with acrylic acid

434-230-1

144413-22-9

R53

R: 53

S: 61

607-683-00-X

mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

435-450-0

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-684-00-5

alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts

435-660-2

243662-67-1

Xi; R38

R43

Xi

R: 38-43

S: (2-)24-37

607-685-00-0

ammonium 2-cocoyloxyethanesulfonate

441-050-7

—

Xi; R38-41

Xi

R: 38-41

S: (2-)26-37/39

607-686-00-6

6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)

441-550-5

—

E; R2

F; R11

Carc. Cat. 3; R40

E; Xn

R: 2-11-40

S: (2-)7-22-36/37

607-687-00-1

mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)

442-800-6

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

607-688-00-7

(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride

444-320-2

—

Xn; R22

Xn

R: 22

S: (2-)

607-689-00-2

mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);

methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)

444-920-4

—

R52-53

R: 52/53

S: 61

607-690-00-8

dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate

432-860-1

255387-46-3

R43

Xi

R: 43

S: (2-)24-37

607-691-00-3

magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear

448-690-6

—

R53

R: 53

S: 61

607-692-00-9

zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear

446-470-4

—

R53

R: 53

S: 61

607-693-00-4

hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate

443-860-6

302776-68-7

R53

R: 53

S: 61

607-694-00-X

ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate

443-870-0

163520-33-0

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-36/37-60-61

608-042-00-7

(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide

421-810-4

194602-27-2

Xn; R22

Xi; R41

R43

N; R51-53

Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61

608-059-00-X

5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile

421-240-6

120068-79-3

N; R51-53

N

R: 51/53

S: 22-61

608-060-00-5

5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile

421-300-1

138564-59-7

N; R50-53

N

R: 50/53

S: 22-60-61

608-062-00-6

2-fluoro-4-hydroxybenzonitrile

422-810-7

82380-18-5

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

608-063-00-1

(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile

441-070-6

61826-76-4

T; R25

Xi; R41

R43

N; R50-53

T; N

R: 25-41-43-50/53

S: (1/2-)9-26-36/37/39-45-60-61

608-064-00-7

cyanomethyltrimethylammoniummethylsulfate

433-720-2

—

R52-53

R: 52/53

S: 61

609-069-00-7

musk ketone;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;

4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone

201-328-9

81-14-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

611-154-00-9

trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate

403-670-6

92408-46-3

R52-53

R: 52/53

S: 61

611-155-00-4

4,4′-oxybis(benzenesulfonylazide)

431-850-4

7456-68-0

E; R3

F; R11

Xn; R48/22

N; R50-53

E; Xn; N

R: 3-11-48/22-50/53

S: (2-)14-22-33-35-36-60-61

611-156-00-X

triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate

432-270-4

221354-37-6

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-62-51/53

S: (2-)36/37-61

611-157-00-5

benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;

potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

432-590-4

243869-48-9

Xi; R36

R52-53

Xi

R: 36-52/53

S: (2-)26-61

611-158-00-0

reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride

421-520-8

—

F; R11

R53

F

R: 11-53

S: (2-)3-12-16-33-61

611-159-00-6

disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate

421-880-6

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-160-00-1

mixture of: 1,1,1-tris(phenyl-4′-(3′′-diazo-3′′,4′′-dihydro-4′′-oxo-naphthalene-1′′-sulfonato)ethane;

1,1,1-tris(phenyl-4′-(6′′-diazo-5′′,6′′-dihydro-5′′-oxo-naphthalene-1′′-sulfonato)ethane;

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

422-760-6

—

F; R11

R53

F

R: 11-53

S: (2-)3-12-33-61

611-161-00-7

trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)

423-100-1

—

Xi; R41

Xi

R: 41

S: (2-)26-39

611-162-00-2

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)

429-600-4

—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-163-00-8

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate

429-610-9

—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-164-00-3

mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;

2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2,2′-dimethyl-2,2′-azoheptanenitrile;

2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)

429-710-2

—

R10

R32

R44

Xn; R22

N; R51-53

Xn; N

R: 10-22-32-44-51/53

S: (2-)12-15-16-47-51-61

611-165-00-9

mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;

tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5

—

R52-53

R: 52/53

S: 61

611-166-00-4

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

432-100-9

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-167-00-X

sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)

435-240-9

—

R52-53

R: 52/53

S: 61

611-168-00-5

mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;

3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

435-440-6

—

Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-169-00-0

sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate

435-800-2

—

R52-53

R: 52/53

S: 61

611-170-00-6

mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);

disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)

435-880-9

—

R52-53

R: 52/53

S: 22-61

611-171-00-1

mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;

trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

436-890-6

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-172-00-7

mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;

diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

438-310-7

—

E; R2

Repr. Cat. 3; R62

Xn; R22-48/22

R52-53

E; Xn

R: 2-22-48/22-62-52/53

S: (2-)22-35-36/37-61

611-173-00-2

mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;

3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

440-510-4

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-26-36/37/39

611-174-00-8

mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

442-290-5

457624-86-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-175-00-3

mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

444-050-5

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-176-00-9

2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate

444-250-2

—

E; R2

F; R11

N; R51-53

E; N

R: 2-11-51/53

S: (2-)22-61

611-177-00-4

mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)

444-290-0

508202-43-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61

611-178-00-X

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

445-280-9

—

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

611-179-00-5

mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;

2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

611-180-00-0

iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts

417-850-7

—

N; R51-53

N

R: 51/53

S: 22-61

612-238-00-8

(3-chloro-2-hydroxypropyl) trimethylammonium chloride ... %

B

222-048-3

3327-22-8

Carc. Cat. 3, R40

R52-53

Xn

R: 40-52/53

S: 36/37-61

612-239-00-3

biphenyl-3,3′,4,4′-tetrayltetraamine;

diaminobenzidine

202-110-6

91-95-2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T

R: 45-68

S: 53-45

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)aniline

—

53112-28-0

N; R51-53

N

R: 51/53

S: 61

612-241-00-4

piperazine hydrochloride; [1]

piperazine dihydrochloride; [2]

piperazine phosphate [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. Cat. 3; R62-63

Xi; R36/38

R42/43

R52-53

Xn

R: 36/38-42/43-62-63-52/53

S: (1/2-)22-36/37-45-63-61

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

—

121552-61-2

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-243-00-5

(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate

420-560-3

79617-97-3

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

C ≥ 10 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2, 5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-244-00-0

3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride

421-310-6

87691-88-1

Repr. Cat. 3; R62

Xn; R22

Xi; R36

R43

N; R50-53

Xn; N

R: 22-36-43-62-50/53

S: (2-)22-26-36/37/39-60-61

612-245-00-6

2-ethylphenylhydrazine hydrochloride

421-460-2

19398-06-2

Carc. Cat. 3; R40

T; R48/25

Xn; R22

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53

10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53

5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-246-00-1

(2-chloroethyl)(3-hydroxypropyl)ammonium chloride

E

429-740-6

40722-80-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/22

R43

R52-53

T

R: 45-46-43-48/22-52/53

S: 53-45-61

612-247-00-7

N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide

423-530-8

152828-23-4

T; R48/25

Xn; R22

R52-53

T

R: 22-48/25-52/53

S: (1/2-)22-36-45-61

612-248-00-2

reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)

439-540-0

—

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)24-37-61

612-249-00-8

4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride

425-030-5

159939-85-2

Repr. Cat. 3; R62

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-43-62-51/53

S: (1/2-)22-26-36/37/39-45-61

612-250-00-3

chloro-N,N-dimethylformiminium chloride

E

425-970-6

3724-43-4

R14

Repr. Cat. 2; R61

Xn; R22

C; R35

T; C

R: 61-14-22-35

S: 53-45

612-251-00-9

cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride

426-020-3

51229-78-8

F; R11

Repr. Cat. 3; R63

Xn; R22

Xi; R38

R43

N; R51-53

F; Xn; N

R: 11-22-38-43-63-51/53

S: (2-)7-22-33-36/37-61

612-252-00-4

imidacloprid (ISO);

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

428-040-8

138261-41-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)22-57-60-61

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing < 0,5 % formamide (EC No 200-842-0)]

429-400-7

199327-61-2

R52-53

R: R52/53

S: 61

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing ≥ 0,5 % formamide (EC No 200-842-0)]

429-400-7

199327-61-2

Repr. Cat. 2; R61

R52-53

T

R: 61-52/53

S: 53-45-61

612-254-00-5

reaction products of diisopropanolamine with formaldehyde (1:4)

432-440-8

220444-73-5

Carc. Cat. 3; R40

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-40-43-51/53

S: (1/2-)13-25-26-36/37/39-45-61

612-255-00-0

1-(3-methoxypropyl)-4-piperidinamine

431-950-8

179474-79-4

Xn; R21/22

C; R34

R52-53

C

R: 21/22-34-52/53

S: (1/2-)26-36/37/39-45-61

612-256-00-6

benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate

427-470-3

137864-22-3

Xn; R22

R43

Xn

R: 22-43

S: (2-)36/37

612-257-00-1

tripropylammonium dihydrogenphosphate

433-700-3

35687-90-2

Xn; R22

Xn

R: 22

S: (2-)22

612-259-00-2

N-ethyl-3-trimethoxysilyl-2-methyl-propanamine

437-720-3

227085-51-0

Xi; R41

Xi

R: 41

S: (2-)26-39

612-261-00-3

3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline

441-190-9

121451-05-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-265-00-5

bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate

444-360-0

191617-13-7

R52-53

R: 52/53

S: 61

612-266-00-0

3-chloro-4-(3-fluorobenzyloxy)aniline

445-590-4

202197-26-0

Muta. Cat. 3; R68

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-68-50/53

S: (2-)22-36/37-60-61

612-267-00-6

bis(hydrogenated tallow C16-18-alkyl)hydroxylamine

418-370-0

—

R43

R53

Xi

R: 43-53

S: (2-)36/37-61

612-269-00-7

mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;

mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

420-720-2

—

R53

R: 53

S: 22-61

612-270-00-2

(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride

433-010-2

—

Xn; R22

R43

R52-53

Xn

R: 22-43-52/53

S: (2-)22-36/37-61

612-271-00-8

mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;

ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

434-970-5

160987-57-5

R53

R: 53

S: 61

612-272-00-3

ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate

435-210-5

—

N; R51-53

N

R: 51/53

S: 61

612-273-00-9

alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride

435-650-8

—

Xn; R22

C; R35

N; R50-53

C; N

R: 22-35-50/53

S: (1/2-)26-36/37/39-45-60-61

612-274-00-4

(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate

445-750-3

—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-24-26-37/39-61

612-275-00-X

fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil

447-880-6

206565-89-1

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 20 %: Xi, N; R38-41-43-50/53

10 % ≤ C < 20 %: Xi, N; R41-43-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-276-00-5

1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts

451-430-4

500717-36-2

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-36/37/39-61

612-277-00-0

mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;

4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

451-440-9

586372-44-3

Xi; R41

Xi

R: 41

S: (2-)22-26-39

612-278-00-6

ethidium bromide;

3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

214-984-6

1239-45-8

Muta. Cat. 3; R68

T+; R26

Xn; R22

T+

R: 22-26-68

S: (1/2-)28-36/37-45-63

612-279-00-1

(R,S)-2-amino-3,3-dimethylbutane amide

447-860-7

144177-62-8

Repr. Cat. 3; R62

Xn; R48/22

Xi; R36/38

R43

Xn

R: 36/38-43-48/22-62

S: (2-)22-26-36/37

612-280-00-7

3-amino-9-ethyl carbazole;

9-ethylcarbazol-3-ylamine

H

205-057-7

132-32-1

Carc. Cat. 2; R45

T

R: 45

S: 53-45

613-116-01-4

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9

731-27-1

Xi; R36/37/38

R43

N; R50

Xi; N

R: 36/37/38-43-50

S: (2-)25-36/37-46-61

C ≥ 20 %: Xi, N; R36/37/38-43-50

2,5 % ≤ C < 20 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;

dimethyl propyleneurea

230-625-6

7226-23-5

Repr. Cat. 3; R62

Xn; R22

Xi; R41

Xn

R: 22-41-62

S: 26-36/37/39

613-281-00-5

quinoline

E

202-051-6

91-22-5

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

N; R51-53

T; N

R: 45-21/22-36/38-68-51/53

S: 53-45-61

613-282-00-0

triticonazole (ISO);

(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—

131983-72-7

N; R51-53

N

R: 51/53

S: 61

613-283-00-6

ketoconazole;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

E

265-667-4

65277-42-1

Repr. Cat. 2; R60

T; R25

Xn; R48/22

N; R50-53

T; N

R: 60-25-48/22-50/53

S: 53-45-60-61

613-284-00-1

metconazole (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—

125116-23-6

Repr. Cat. 3; R63

Xn; R22

N; R51-53

Xn; N

R: 22-63-51/53

S: (2-)36/37-46-61

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]

1-hydroxybenzotriazole, monohydrated [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

E; R2

E

R: 2

S: 16-35

613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2

183196-57-8

R43

Xi

R: 43

S: (2-)24-37

613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2

183196-57-8

Repr. Cat. 2; R61

R43

T

R: 61-43

S: 53-45

613-287-00-8

1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole

419-540-7

160194-26-3

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-288-00-3

1,3-bis(dimethylcarbamoyl)-imidazolium chloride

420-930-4

135756-61-5

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-37/39-61

613-289-00-9

3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole

432-020-4

142623-48-1

N; R50-53

N

R: 50/53

S: 60-61

613-290-00-4

4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride

432-470-1

189012-93-9

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61

613-291-00-X

2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

434-820-9

106461-41-0

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

613-292-00-5

N,N′,N′′-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine

435-010-8

26157-73-3

Muta. Cat. 3; R68

R52-53

Xn

R: 68-52/53

S: (2-)36/37-61

613-293-00-0

2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester

448-050-6

444065-11-6

R53

R: 53

S: 61

613-294-00-6

2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester

448-260-8

379268-96-9

R53

R: 53

S: 61

613-295-00-1

11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride

448-720-8

363138-44-7

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-39-61

613-296-00-7

pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate

418-270-7

—

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-47-61

613-297-00-2

5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole

420-820-6

—

R10

Xn; R22

N; R51-53

Xn; N

R: 10-22-51/53

S: (2-)16-61

613-298-00-8

bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate

421-560-6

—

Xn; R48/22

Xi; R41

N; R51-53

Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61

613-299-00-3

main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt

422-610-1

—

Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-300-00-7

1-imidazol-1-yl-octadecan-2-ol

434-120-3

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

613-301-00-2

dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate

443-910-7

—

R53

R: 53

S: 61

613-302-00-8

disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate

432-980-4

243858-60-8

Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-303-00-3

2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine

429-800-1

95737-68-1

N; R50-53

N

R: 50/53

S: 60-61

613-304-00-9

5,6-dihydroxy-2,3-dihydro-1H-indolium bromide

421-170-6

138937-28-7

Xn; R22

Xi; R41

Xn

R: 22-41

S: (2-)22-26-39

613-305-00-4

2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole

448-630-9

3147-77-1

R53

R: 53

S: 61

613-306-00-X

(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate

433-520-5

82911-69-1

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-307-00-5

clothianidin (ISO);

3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

—

210880-92-5

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R22-50/53

2,5 % ≤ C < 25 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

613-308-00-0

2-amino-5-methylthiazole

423-800-5

7305-71-7

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-50/53

S: (2-)22-36-60-61

613-309-00-6

1-methyl-3-phenyl-1-piperazine

431-180-2

5271-27-2

Xn; R21/22

Xi; R38-41

R52-53

Xn

R: 21/22-38-41-52/53

S: (2-)26-36/37/39-61

613-310-00-1

(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride

432-360-3

105813-13-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61

613-311-00-7

methyl-5-nitrophenyl-guanidine

435-500-1

152460-07-6

Xn; R22

Xi; R36

R43

R52-53

Xn

R: 22-36-43-52/53

S: (2-)22-24-26-37-61

613-312-00-2

2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride

420-200-5

—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-26-36/37/39-61

613-313-00-8

2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione

442-780-9

173838-67-0

R52-53

R: 52/53

S: 61

613-314-00-3

4-decyloxazolidin-2-one;

4-decyl-1,3-oxazolidin-2-one

443-770-7

7693-82-5

N; R50-53

N

R: 50/53

S: 22-24-60-61

613-315-00-9

tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate

430-390-1

—

Xn; R20

R52-53

Xn

R: 20-52/53

S: (2-)25-61

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);

(TAZ)

H

257-765-0

52234-82-9

Muta. Cat. 3; R68

Xi; R41

R43

Xn

R: 41-43-68

S: 26-36/37/39-42

615-044-00-1

4-chlorophenylisocyanate

203-176-9

104-12-1

T+; R26

Xn; R22

Xi; R37/38-41

R42

N; R50-53

T+; N

R: 22-26-37/38-41-42-50/53

S: (1/2-)26-28-36/37/39-45-63-60-61

615-045-00-7

4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)

420-530-1

—

R42/43

R53

Xn

R: 42/43-53

S: (2-)23-24-37-45-61

616-126-00-X

1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide

423-960-6

139756-01-7

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36/37-61

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

—

149961-52-4

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20

N; R50-53

Xn; N

R: 20-40-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-40-63-50/53

5 % ≤ C < 25 %: Xn, N; R40-63-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52-53

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide

—

113614-08-7

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 0,25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

616-166-00-8

cyazofamid (ISO);

4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

—

120116-88-3

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 2,5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51-53

0,025 % ≤ C < 0,25 %: R52/53

616-167-00-3

N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide

418-290-6

168612-06-4

Xi; R36

R43

Xi

R: 36-43

S: (2-)24-26-37

616-168-00-9

1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium

418-440-0

136997-71-2

R43

Xi

R: 43

S: (2-)22-24-37

616-169-00-4

4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one

420-220-4

92771-56-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-170-00-X

(2R)-2-amino-2-phenylacetamide

420-370-0

6485-67-2

Xi; R36

R43

Xi

R: 36-43

S: (2-)22-26-36/37

616-171-00-5

2-(para-chlorophenyl)glycineamide

420-830-0

102333-75-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-3

14691-89-5

Xn; R22

Xn

R: 22

S: (2-)22

616-174-00-1

2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride

424-560-4

151257-01-1

Xn; R22

Xi; R36

Xn

R: 22-36

S: (2-)22-26

616-175-00-7

2-(2-hexyldecyloxy)benzamide

431-230-3

202483-62-3

R53

R: 53

S: 61

616-176-00-2

3-N,N-bis(methoxyethyl)aminoacetanilide

432-530-7

24294-01-7

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)22-24-61

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide

432-970-1

217324-98-6

R53

R: 53

S: 61

616-178-00-3

N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide

434-500-9

52583-35-4

R53

R: 53

S: 22-61

616-179-00-9

2-chloro-N-(4-methylphenyl)acetamide

435-170-9

16634-82-5

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)22-26-36/37/39-60-61

616-180-00-4

N,N-(dimethylamino)thioacetamide hydrochloride

435-470-1

27366-72-9

Repr. Cat. 2; R61

N; R50-53

T; N

R: 61-50/53

S: 53-45-60-61

616-181-00-X

4′-methyldodecane-1-sulfonanilide

435-490-9

17417-32-2

N; R50-53

N

R: 50/53

S: 60-61

616-182-00-5

N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide

435-860-1

214417-91-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

616-183-00-0

N-dodecyl-4-methoxybenzamide

442-340-6

1854-15-5

R53

R: 53

S: 61

616-184-00-6

3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide

442-560-2

105043-55-8

R53

R: 53

S: 61

616-186-00-7

N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)

443-010-4

53641-10-4

R52-53

R: 52/53

S: 61

616-188-00-8

2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide

443-980-9

221215-20-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-189-00-3

N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide

444-780-4

452962-97-9

R53

R: 53

S: 61

616-190-00-9

N-decyl-4-nitrobenzamide

445-880-0

64026-19-3

R53

R: 53

S: 61

616-191-00-4

2-ethyl-N-methyl-N-(3-methylphenyl)butanamide

446-190-2

406488-30-0

Xn; R22

Xi; R36/38

R43

N; R51-53

Xn; N

R: 22-36/38-43-51/53

S: (2-)24-26-37-61

616-192-00-X

2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide

448-060-0

727678-39-9

R53

R: 53

S: 61

616-193-00-5

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide

449-940-7

368450-39-9

R53

R: 53

S: 61

616-194-00-0

2,2-diethoxy-N,N-dimethylacetamide

449-950-1

34640-92-1

Xi; R36

Xi

R: 36

S: (2-)26

616-196-00-1

disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide

419-990-4

—

N; R50-53

N

R: 50/53

S: 60-61

616-197-00-7

mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

422-500-1

—

Xn; R48/22

Xn

R: 48/22

S: (2-)22-36

616-198-00-2

1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene

423-300-7

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-200-00-1

mixture of: N,N′-ethane-1,2-diylbis(hexanamide);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)

432-430-3

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-201-00-7

12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine

432-840-2

220926-97-6

Xn; R20

R53

Xn

R: 20-53

S: (2-)22-61

616-202-00-2

mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

434-330-5

—

Carc. Cat. 3; R40

R43

R53

Xn

R: 40-43-53

S: (2-)36/37-61

616-203-00-8

mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide

442-280-0

—

R53

R: 53

S: 61

616-204-00-3

N,N′′-(methylenedi-4,1-phenylene)bis[N′-octylurea]

451-060-3

122886-55-9

R53

R: 53

S: 61

617-022-00-7

mixture of: 1,2-dimethylpropylidene dihydroperoxide;

dimethyl 1,2-benzenedicarboxylate

442-480-8

—

O; R7

Xn; R22

C; R34

R43

N; R51-53

O; C; N

R: 7-22-34-43-51/53

S: (1/2-)3/7-14-26-36/37/39-45-50-61

647-017-00-5

laccase

420-150-4

80498-15-3

R42

Xn

R: 42

S: (2-)23-45

---

ANNEX 1C

The entries in Annex I with the following Index numbers are deleted:

024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.

---